Gut microbiota and risk of ovarian diseases: a two-sample Mendelian randomization study | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Gut microbiota and risk of ovarian diseases: a two-sample Mendelian randomization study Xueying Liu, Kejing Zhu, Renke He, Zhaoying Jiang, Haiyan Wu, and 6 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-4188266/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Background Previous studies have reported an association between gut microbial dysbiosis and ovarian diseases, however, it is not clear whether a causal association exists. Methods Two-sample Mendelian randomization (MR) analysis was performed to genetically predict the causal effects of the gut microbiota on polycystic ovary syndrome (PCOS), premature ovarian failure (POF), ovarian endometriosis, and malignant and benign ovarian neoplasms. The inverse variance weighted (IVW) method was used as the primary statistical method. A series of sensitivity analyses, including weighted median, MR-Egger, simple mode, weighted mode methods, MR pleiotropy residual sum and outlier (MR-PRESSO) and leave-one-out analysis, were also conducted to assess the robustness of the MR analysis results. Reverse MR analysis was implemented to explore whether ovarian diseases have any causal impact on the bacterial genera. Additionally, the Cochran’s Q test was used to evaluate heterogeneity among instrumental variables. Results IVW analysis revealed that several bacteria were associated with decreased risk of PCOS, POF, ovarian endometriosis, and benign and malignant ovarian neoplasm. Moreover, several bacteria were the causes of increased risks for POF, ovarian endometriosis, and benign and malignant ovarian neoplasm, respectively. Reverse MR analysis did not reveal a significant causal effect of these ovarian diseases on the gut microbiota. These findings were robust according to extensive sensitivity analyses. Conclusion Our results provide genetic evidence to support the causal relationship between specific gut microbiota taxa and ovarian diseases; thus, the gut microbiota should be considered a preventative strategy for ovarian diseases. gut microbiota polycystic ovary syndrome premature ovarian failure ovarian endometriosis ovarian neoplasm Mendelian randomization Figures Figure 1 Figure 2 1. Introduction The ovary is essential for establishing and maintaining secondary sexual characteristics and fertility in females. However, ovarian diseases, such as polycystic ovary syndrome (PCOS), premature ovarian failure (POF), ovarian endometriosis and ovarian neoplasm, negatively influence reproductive health and induce disorders of ovarian function. PCOS is one of the most common reproductive endocrine and metabolic disorders, and common signs of PCOS are ovulatory dysfunction, excess androgen exposure and the presence of polycystic ovaries, which can impair fertility [ 1 ]. POF refers to the exhaustion of the ovarian reserve before the age of 40 years. Given that the chance of spontaneous conception is 5%-10% [ 2 ],adoption or in vitro fertilization and embryo transfer using donor oocytes are considered effective fertility treatments for women with POF. Radiotherapy, chemotherapy, and pelvic surgery for malignant and benign conditions, including ovarian endometriomas and ovarian cancer, can negatively affect the ovarian reserve [ 2 , 3 ] and even lead to POF [ 4 ]. Unfortunately, the potential causes and molecular mechanisms of these ovarian diseases have not yet been elucidated. More recently, the gastrointestinal tract, which hosts ten trillion diverse symbionts (50 bacterial phyla and approximately 100–1000 bacterial species), has been extensively studied owing to its basic functions in the immunological, metabolic, structural and neurological landscapes in humans [ 5 ]. Recent research has shown that the interaction of the female reproductive endocrine system with estrogen, androgens, insulin, and other hormones appears to be crucial for successful pregnancy [ 6 ]. Several observational studies have suggested that an imbalance in gut microbiota stabilization may induce PCOS [ 7 – 10 ], endometriosis [ 11 , 12 ], ovarian dysfunction [ 13 ] and ovarian cancer [ 14 ] in women. However, less is known about the exact role of the gut microbiota in ovarian physiology, and few studies have explored the causal relationship between the gut microbiota and certain diseases [ 15 ]. Establishing the causal relationship between specific gut bacteria and certain ovarian diseases would be highly valuable for the prevention and treatment of this disease. Although randomized controlled trials (RCTs) are the gold standard for establishing causal relationships, they can be costly, time-consuming and even impractical [ 16 ]. On the other hand, observational studies may not robustly reflect causal relationships owing to many potential biases, confounders and reverse causation [ 17 ]. Mendelian randomization (MR) is an approach that uses genetic variants associated with an exposure as instrumental variables (IVs) to examine the causality of exposure–outcome associations. MR can minimize potential confounders and reverse causality as genetic variants segregate randomly and independently and precede the outcome of interest [ 16 ]. Furthermore, during the last decade, the publication of a large volume of genome-wide association studies (GWASs) has led to the conduction of MR studies without the need to recruit new patients. Therefore, MR offers a suitable means to infer the causal effect between the gut microbiota and the risk of ovarian disease. Here, we implemented bidirectional MR analyses to explore the causal relationship between the gut microbiota and ovarian diseases. 2. Materials and Methods We assessed the causal links between the gut microbiota and five ovarian diseases using two-sample MR. An overview of the analytical approach is shown in Fig. 1 a. 2.1 Exposure data We obtained genetic variant information related to the human gut microbiome composition from the latest large-scale genome-wide meta-analysis conducted by the MiBioGen consortium ( https://mibiogen.gcc.rug.nl/ .) based on European-dominated participants [ 18 ]. This study analyzed genome-wide genotypes and 16S fecal microbiome data from 18,340 individuals from 24 cohorts. Accordingly, the genus level was the lowest. A total of 131 genera with a mean abundance greater than 1% were identified, 12 of which were unknown genera [ 18 ]. As a result, we included 119 genus-level taxa in the present study. 2.2 Outcome data We obtained genetic variants related to the human gut microbiome composition from the latest large-scale genome-wide meta-analysis conducted by the MiBioGen consortium. https//mibiogen.gcc.rug.nl/.) based on European-dominated participants [ 18 ]. This study analyzed genome-wide genotype and 16S fecal microbiome data from 18,340 individuals from 24 cohorts. Accordingly, the genus level was the lowest. A total of 131 genera with a mean abundance greater than 1% were identified, 12 of which were unknown genera [ 18 ]. As a result, we included 119 genus-level taxa in the present study. 2.3 Instrumental variable selection Single-nucleotide polymorphisms (SNPs) are used as IVs in MR analysis to provide evidence of causality between an exposure and outcome. To ensure the accuracy and robustness of the causal link, SNPs must satisfy three core assumptions to be used as IVs (Fig. 1 b) [ 19 ]. Therefore, the following steps were conducted. First, we selected independent SNPs (linkage disequilibrium R 2 < 0.001 and clumping distance = 10,000 kb, based on the European-based 1000 Genome Projects reference panel) associated with each genus at a locus-wide threshold of significance ( P < 1× 10 − 5 ). Second, the minor allele frequency (MAF) threshold of the variants of interest was 0.01. Third, allele frequency information was used to infer that palindromic SNPs were aligned in the same direction for exposure and outcome. 2.4 Statistical analysis The inverse variance weighted (IVW) method was used as the primary statistical method and can provide the most accurate causal estimates provided that the pleiotropic effect is balanced and that all IVs meet the MR assumptions [ 10 ]. Since it is difficult to verify that IVs influence the outcome only through the exposure of interest, we performed a series of sensitivity analyses with different assumptions to assess the robustness of the associations and to examine horizontal pleiotropy for exposures, including weighted median, MR‒Egger simple mode weighted mode and MR pleiotropy residual sum and outlier (MR-PRESSO) analyses. The weighted median of SNP-specific estimates provides valid estimates when more than 50% of the information is contributed from the IVs [ 20 ]. MR-Egger regression provides a valid estimate of causal estimates under the instrument strength independent of direct effect (InSIDE) assumption [ 21 ]. However, this approach was used to detect and adjust for unbalanced horizontal pleiotropy rather than to produce causal estimates due to the low statistical power of MR-Egger. A MR-Egger intercept significantly different from 0 ( P < 0.05) indicated the occurrence of directional pleiotropy and a potentially biased IVW estimate. In addition, horizontal pleiotropy was also assessed by employing the MR-PRESSO global test, and where evident, the MR‐PRESSO outlier test was used to exclude outlying SNPs and correct the IVW estimate [ 22 ]. To further test the robustness of our results, Cochran’s Q test was used to evaluate heterogeneity among the SNPs included in each analysis. Q statistics significant at P < 0.05 provide evidence for heterogeneity between individual genetic variants and the existence of invalid instruments [ 23 ]. In addition, leave-one-out analysis was performed to assess whether an outcome was driven by a single outlying SNP [ 24 ], indicating the presence of heterogeneous SNPs. Furthermore, if the genetic variants do not explain enough of the variance, there will be significant weak instrumental bias toward the confounded estimate [ 25 ]. To address this concern, SNP–specific F-statistics, approximated by the square of the beta divided by the variance for the SNP–exposure association, were calculated to evaluate the strength of the instruments used, and values exceeding the standard threshold of 10 are indicative of strong genetic instruments [ 25 ]. To explore whether ovarian diseases have any causal impact on the bacterial genera that were found to be causally associated with ovarian diseases in forward MR analysis, we also performed a reverse MR analysis using SNPs that are associated with each ovarian disease at a threshold smaller than the locus-wide significance level (5 × 10 − 6 ) as IVs. All tests were two-sided and performed using R Version 4.2.1 with the R packages “TwoSampleMR”, “MendelianRandomization” and “MR-PRESSO”. A P value < 0.05 indicated statistical significance of the MR effect estimate. No ethical approval was required since we used publicly available summary data. 3. Results 3.1 SNP selection There were 1508 SNPs selected for the MR analyses according to the IV selection criteria. The detailed information and F-statistic for the selected instruments are shown in Supplementary Table 2. The overall instrument had a high F-statistic (> 10), indicating the good strength of the genetic instruments used. 3.2 Causal effects of the gut microbiome on ovarian diseases Figure 2 shows causal effect estimates of the gut microbiota on PCOS, POF, ovarian endometriosis, and ovarian neoplasm from the IVW MR analyses. Associations for individual SNPs using the different MR methods are presented in Supplementary Table 3–7. Scatter and forest plots of the SNP-outcome associations against the SNP-exposure associations are shown in Supplementary Figs. 1–10, allowing visualization of the causal effect estimate for each individual SNP on PCOS, POF, ovarian endometriosis, and ovarian neoplasm. Leave-one-out plots are shown in Supplementary Fig. 11–15 to evaluate the influential outliers. 3.2.1 PCOS MR analysis via the IVW method showed that Barnesiella , Bilophila , and Holdemania were negatively associated with the risk of PCOS odds ratio (OR) = 0.55, 95%Cl, 0.36–0.84, P = 0.005; OR = 0.58, 95%Cl, 0.37–0.92, P = 0.021; OR = 0.64, 95%Cl, 0.47–0.88, P = 0.005 (Fig. 2 ). According to the reverse MR analysis by the IVW method, no significant causal association was found between PCOS and these three bacterial genera (Supplementary Table 18). 3.2.2 POF MR analysis via the IVW method revealed that Eubacterium (hallii group) and Eubacterium (ventriosum group) were negatively associated with the risk of POF (OR = 0.49, 95% Cl, 0.26–0.90, P = 0.022; OR = 0.51, 95% Cl, 0.27–0.97, P = 0.040), while Adlercreutzia , Intestinibacter , Lachnospiraceae (UCG008) , and Terrisporobacter were positively associated with the risk of POF (OR = 3.01, 95% Cl, 1.38–6.60, P = 0.006; OR = 1.82, 95% Cl, 1.04–3.20, P = 0.037; OR = 1.73, 95% Cl, 1.08–2.76, P = 0.023; OR = 2.47, 95% Cl, 1.14–5.36, P = 0.022) (Fig. 2 ). According to the reverse MR analysis by the IVW method, no significant causal association was found between POF and these six bacterial genera (Supplementary Table 19). 3.2.3 Ovarian endometriosis MR analysis via the IVW method showed that Intestinimonas was positively associated with the risk of ovarian endometriosis (OR = 1.21, 95% Cl, 1.03–1.42, P = 0.018), while Rikenellaceae ( RC9gut group) and Ruminococcaceae (UCG013) were negatively associated with the risk of ovarian endometriosis (OR = 0.88, 95% Cl, 0.80–0.98, P = 0.017; OR = 0.78, 95% Cl, 0.63–0.98, P = 0.030) (Fig. 2 ). According to the reverse MR analysis by the IVW method, no significant causal association was found between ovarian endometriosis and these three bacterial genera (Supplementary Table 20). 3.2.4 Benign ovarian neoplasm MR analysis via the IVW method revealed that Eubacterium (nodatum group) was positively associated with the risk of benign ovarian neoplasm (OR = 1.15, 95% Cl, 1.01–1.31, P = 0.039), while Ruminococcus (torques group) , Barnesiella , and Blautia were negatively associated with the risk of benign ovarian neoplasm (OR = 0.65, 95% Cl, 0.48–0.88, P = 0.006; OR = 0.79, 95% Cl, 0.63–0.99, P = 0.038; OR = 0.78, 95% Cl, 0.62–1.00, P = 0.046) (Fig. 2 ). According to the reverse MR analysis by the IVW method, no significant causal associations were found between benign ovarian neoplasms and these four bacterial genera (Supplementary Table 21). 3.2.5 Malignant ovarian neoplasms MR analysis via the IVW method revealed that Lachnospiraceae (UCG008) and Ruminococcaceae (UCG011) were positively associated with the risk of malignant ovarian neoplasms (OR = 1.44, 95% Cl, 1.10–1.90, P = 0.009; OR = 1.35, 95% Cl, 1.01–1.80, P = 0.039), while Paraprevotella , Ruminococcaceae (UCG005) , Senegalimassilia , and Slackia were negatively associated with the risk of malignant ovarian neoplasms (OR = 0.72, 95% Cl, 0.54–0.95, P = 0.022; OR = 0.64, 95% Cl, 0.45–0.92, P = 0.016; OR = 0.59, 95% Cl, 0.36–0.94, P = 0.029; OR = 0.66, 95% Cl, 0.44–0.98, P = 0.039) (Fig. 2 ). According to the reverse MR analysis by the IVW method, no significant causal association was found between malignant ovarian neoplasms and these six bacterial genera (Supplementary Table 22). 3.2.6 Sensitivity analyses The observed causal associations were consistent in sensitivity analyses. There was no evidence of significant heterogeneity or directional pleiotropy using Cochran’s Q test, MR Egger intercepts or MR-PRESSO in our study (Table 1 and Supplementary Table 8–12). No outliers were visually inspected in either the scatter (Supplementary Figs. 1–5) or forest plots (Supplementary Figs. 6–10). Furthermore, the leave-one-out analysis suggested that the observed associations remained consistent after eliminating each single SNP at a time (Supplementary Figs. 11–15), suggesting the robustness of the results. Table 1 Heterogeneity and directional pleiotropy tests from MR analysis of the gut microbiota and risk of ovarian diseases. Outcome Exposure Heterogeneity MR‒Egger MR-PRESSO Cochrane’s Q P Egger Intercept SE P intercept Causal Estimate Global Test P PCOS Barnesiella 4.80 0.941 -0.01 0.07 0.837 -0.60 0.940 Bilophila 15.61 0.210 -0.03 0.09 0.704 -0.54 0.225 Holdemania 7.94 0.847 -0.01 0.05 0.821 -0.44 0.864 POF Eubacterium (hallii group) 9.01 0.773 -0.01 0.05 0.916 -0.72 0.795 Eubacterium (ventriosum group) 10.02 0.761 -0.02 0.11 0.858 -0.68 0.764 Adlercreutzia 9.55 0.215 0.28 0.14 0.085 1.10 0.271 Intestinibacter 12.90 0.535 -0.08 0.08 0.307 0.60 0.558 Lachnospiraceae (UCG008) 10.44 0.491 0.10 0.12 0.446 0.55 0.505 Terrisporobacter 2.93 0.570 0.05 0.12 0.703 0.90 0.603 Ovarian endometriosis Intestinimonas 10.96 0.756 0.02 0.02 0.388 0.19 0.756 Rikenellaceae (RC9gut group) 11.01 0.443 0.08 0.04 0.092 -0.12 0.465 Ruminococcaceae (UCG013) 9.09 0.523 -0.01 0.02 0.730 -0.24 0.542 Benign ovarian neoplasm Eubacterium (nodatum group) 13.97 0.174 -0.05 0.04 0.269 0.14 0.200 Ruminococcus (torques group) 5.10 0.647 -0.03 0.03 0.351 -0.43 0.703 Barnesiella 12.03 0.362 0.04 0.03 0.289 -0.24 0.376 Blautia 10.85 0.456 0.03 0.02 0.269 -0.24 0.446 Malignant ovarian neoplasm Lachnospiraceae (UCG008) 7.33 0.772 0.14 0.07 0.074 0.37 0.785 Paraprevotella 14.63 0.262 0.02 0.06 0.719 -0.33 0.292 Ruminococcaceae (UCG005) 11.76 0.547 -0.02 0.04 0.682 -0.44 0.592 Ruminococcaceae (UCG011) 9.64 0.210 -0.05 0.10 0.668 0.30 0.256 Senegalimassili 1.64 0.801 0.07 0.09 0.478 -0.54 0.813 Slackia 3.52 0.620 -0.07 0.13 0.643 -0.42 0.656 PCOS, polycystic ovary syndrome; POF, premature ovarian failure; MR, Mendelian randomization. 4. Discussion We conducted MR analyses by using the largest GWAS dataset to systematically investigate the causal relationship between the gut microbiota and the risk of ovarian diseases. Our results showed that there were causal effects of several genetically predicted genera of the gut microbiota on the risk of PCOS, POF, ovarian endometriosis and ovarian neoplasm. The positive or negative relationships between the gut microbiota and certain ovarian diseases were further verified by sensitivity analyses. This study could provide important insight into the genetic relationship between the gut microbiome and ovarian diseases and shed new light on the potential causes and therapeutic strategies for ovarian diseases. 4.1 The potential role of the gut microbiota in PCOS Recent studies have demonstrated that gut microbes play vital roles in the etiology of PCOS [ 26 ]. In this study, we found that Barnesiella , Bilophila and Holdemania had protective effects on PCOS, which has not been demonstrated previously [ 7 – 9 ]. Evidence from other studies has demonstrated that the gut microbiome and its metabolites are involved in the pathogenesis of hyperandrogenaemia and insulin resistance, which are salient features of PCOS [ 27 – 29 ]. Barnesiella was reported to be short-chain fatty acid (SCFA)-producing bacteria [ 27 , 30 ]. SCFAs, including propionate, acetate and butyrate, are the main products of the fermentation of dietary fiber by the intestinal microbiota [ 31 ]. Butyrate can enhance the expression of tight-junction proteins and mucin to maintain the intestinal epithelial barrier [ 32 ], which is the first line of defense in the intestine. On the other hand, SCFAs beneficially affect the metabolic process of the host, especially insulin resistance. Data from human and animal studies have demonstrated that acetate promotes host metabolism and improves insulin sensitivity through the secretion of a gut hormone, which inhibits appetite and reduces lipolysis and systemic proinflammatory cytokine levels [ 33 ]. Furthermore, a study suggested that propionate and butyrate activate intestinal gluconeogenesis via complementary mechanisms [ 34 ]. Hence, Barnesiella may reduce the risk of PCOS through the biological functions of SCFAs. Barrett et al. [ 35 , 36 ] reported that Holdemania abundance was positively associated with the intake of dietary fiber, overall polyunsaturated fat (PUFA) and both ω-3 and ω-6 PUFAs. In addition, it has been documented that adequate intake of dietary fiber and supplementation with PUFAs are both conducive to improving glucose metabolism and lipid profiles [ 37 , 38 ]. Holdemania may exert important effects on metabolic status in PCOS patients through the beneficial influence of dietary fiber and PUFAs, but further studies are needed to prove this assumption. Although Bilophila has been shown to mitigate cardiovascular disease by metabolizing both trimethylamine and its precursors without the production of trimethylamine-N-oxide [ 39 ], no evidence has been reported for the positive effect of Bilophila on PCOS, and additional in-depth studies are needed to explore the underlying mechanism involved. 4.2 The potential role of the gut microbiota in POF Altered gut microbial profiles have been abserved in women with POF [ 13 ]. Additionally, Elgart et al. [ 40 ] reported that the gut bacteria of Drosophila can affect oogenesis and maternal-to-zygotic transition during embryo development. In this study, we found that Eubacterium (hallii group) and Eubacterium (ventriosum group) had protective effects on POF. Eubacterium produces SCFAs. The abundance of Eubacterium in the gut is strongly correlated with SCFA levels and the beneficial effects of SCFAs under a range of clinical conditions [ 41 ].Several studies have shown that SCFAs play a major role in the modulation of inflammation through the inhibition of proinflammatory cytokines, such as interferon (IFN)-γ, interleukin (IL)-1β, IL-6, IL-8, and tumor necrosis factor receptor-α (TNF-α), while upregulating the expression of anti-inflammatory cytokines, such as IL-10 and transforming growth factor-β (TGF-β) [ 42 , 43 ]. The human ovary is a ubiquitous target for autoimmune attack, leading to the consequent occurrence of POF [ 44 ]. Autoimmunity is responsible for approximately 4–30% of POF cases [ 45 , 46 ]. E. hallii and E. ventriosum may act as anti-inflammatory agents to protect the ovary from inflammation. On the other hand, we found that Adlercreutzia , Intestinibacter , Lachnospiraceae (UCG008 ), and Terrisporobacter increased the risk of POF. Other studies have shown that these 4 gut microbiome taxa are correlated with the risk of diabetic retinopathy, male infertility, periodontitis, and sepsis [ 47 – 50 ]. However, there is a lack of corresponding research evidence to clarify the underlying mechanism by which these gut microbiome taxa contribute to POF, thus providing new directions for future studies. 4.3 The potential role of the gut microbiota in ovarian endometriosis Endometriosis has been associated with several factors, including unopposed estrogen signaling, resistance to progesterone, altered immune function and epigenetic modifications [ 51 ]. Because the gut microbiota can affect estrogen metabolism and inflammation, a growing body of recent evidence suggests that the gut microbiota may be closely involved in the onset and progression of endometriosis. Microbially secreted β-glucuronidases are functional members of the estrobolome [ 52 ]. β-glucuronidases can deconjugate estrogen and enable it to bind to estrogen receptors, leading to its subsequent downstream effects [ 52 ]. Ata et al. [ 11 ] observed differences in microbiota composition at the genus level between the stage 3/4 endometriosis group and the control group. Patients with endometriosis may harbor more β-glucuronidase-producing bacteria to increase the level of deconjugate estrogen and therefore drive endometriosis [ 53 ]. On the other hand, Khan et al. [ 54 ] indicated that higher levels of Escherichia coli in menstrual blood may contribute to higher levels of endotoxin in the menstrual fluid and peritoneal fluid, which may promote the Toll-like receptor 4-mediated growth of endometriosis. E. coli or endotoxin from the gut may translocate into the pelvis through enterocytes [ 54 ]. In this study, we demonstrated that Intestinimonas increased the risk of ovarian endometriosis, while Rikenellaceae (RC9gut group) and Ruminococcaceae (UCG013) decreased the risk. It is unclear whether Intestinimonas , Rikenellaceae (RC9gut group) and Ruminococcaceae (UCG013) are involved in estrogen metabolism and inflammation modulation and thus participate in the onset and progression of endometriosis. These findings should be validated in the future to help develop therapeutic interventions for endometriosis. 4.4 The potential role of the gut microbiota in ovarian neoplasms In recent years, microbial roles in cancer formation, diagnosis, prognosis and treatment have emerged as debated issues. The gut microbiota can accelerate cell proliferation or cellular death, disturb the immune system and alter metabolism within host cells [ 55 ]; however, the exact mechanism through which bacteria influence tumorigenesis has not been elucidated. The gut microbiome of patients with epithelial ovarian cancer differs from that of healthy women, and the abundance of beneficial bacteria, including Bifidobacterium and Ruminococcus , decreases. The gut microbiota can promote ovarian tumor progression through activation of Hedgehog signaling mediated by TLR4/NF-κB signaling [ 14 ]. In addition, animal study have shown that intestinal dysbiosis can significantly provoke the activation of macrophages and consequently increase the production of TNF-α and IL-6, and ultimately contributes to the development of epithelial-mesenchymal transition, resulting in the development of advanced ovarian cancer [ 56 ]. In this study, we found that Lachnospiraceae (UCG008) and Ruminococcaceae (UCG011) were positively associated with the risk of malignant ovarian neoplasm, while Paraprevotella , Ruminococcaceae (UCG005) , Senegalimassilia and Slackia were negatively associated with the risk of malignant ovarian neoplasm. A study showed that Lachnospiraceae (UCG008) was positively correlated with the levels of proinflammatory cytokines, such as IL-6, high-sensitivity C-reactive protein and TNF-α [ 57 ], in the peripheral blood, possibly leading to tumor progression through its proinflammatory effect. On the other hand, Gebeyew et al. [ 58 ] demonstrated that the relative abundance of Ruminococcaceae (UCG005) was positively associated with propionate, iso-butyrate acetate, butyrate, and valeric acid. These SCFAs exert anti-inflammatory effects by regulating cytokine production and immune cell functions and may inhibit tumor progression through their anti-inflammatory effects [ 59 ]. Since there is currently no research exploring the relationship between these gut microbiota and ovarian neoplasms, the exact mechanism connecting these four bacterial genera with ovarian neoplasms has been unclear until recently and warrants additional study. To conclude, we first provide evidence to support the causal relationship between specific gut microbiota taxa and ovarian diseases through MR analyses, thus providing effective preventive and predictive measures for ovarian diseases. However, further research is necessary to validate these findings and explore the underlying mechanisms in clinical trials and animal models. Declarations Ethics approval and consent to participate Not applicable. Only publicly available summary statistics were used. Consent for publication Not applicable. Availability of data and materials Data generated in the present study are provided within the main text and supplementary materials. Genetic instrumental variables and data sources are presented in the supplementary files. The exposure and outcome data can be obtained via www.mibiogen.org and https://www.r8.finngen.fi/. Competing Interests The authors have no relevant financial or non-financial interests to disclose. Funding This research was funded by National Key Research and Development Program of China (No. 2022YFC2703803, No.2022YFC2703000, No.2021YFC2700603), National Natural Science Foundation of China (No.82088102, No.82171613, No.82171688), Collaborative Innovation Program of Shanghai Municipal Health Commission (No.2020CXJQ01), Shanghai Frontiers Science Center of Reproduction and Development, CAMS Innovation Fund for Medical Sciences (No.2019-I2M-5-064), Clinical Research Plan of SHDC (No.SHDC2020CR1008A), Shanghai Clinical Research Center for Gynecological Diseases (22MC1940200), Shanghai Urogenital System Diseases Research Center (2022ZZ01012), Shanghai Frontiers Science Research Center of Reproduction and Development. Key Discipline Construction Project (2023-2025) of Three-Year Initiative Plan for Strengthening Public Health System Construction in Shanghai (GWVI-11.1-35), Zhejiang Province College Student Science and Technology Innovation Program (Xinmiao Plan) (2023R401210). Authors' contributions H.H., J.S. and J.P. designed the study. X.L. and Z.L. conducted statistical analysis and drafted the manuscript. K.Z., R.H., Z.J., H.W., J.Y. and Q.L. assisted in statistical analysis and manuscript drafting. J.P. and H.H. revised the manuscript critically. All authors have read and agreed to the published version of the manuscript. Acknowledgments We express our gratitude to the participants of the FinnGen study and the MiBioGen consortium for releasing the gut microbiota GWAS summary statistics. References Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev. 2015;36:487–525. https://doi.org/10.1210/er.2015-1018 . Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update. 2005;11:391–410. https://doi.org/10.1093/humupd/dmi012 . Oral E, Demir B, Inceboz U. Endometriosis and ovarian reserve. Women's health (Lond). 2015;11:671–5. https://doi.org/10.2217/whe.15.53 . Howell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am. 1998;27:927–43. https://doi.org/10.1016/s0889-8529(05)70048-7 . Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci. 2019;76:473–93. https://doi.org/10.1007/s00018-018-2943-4 . Qi X, Yun C, Pang Y, Qiao J. The impact of the gut microbiota on the reproductive and metabolic endocrine system. Gut Microbes. 2021;13:1–21. https://doi.org/10.1080/19490976.2021.1894070 . Zhou L, Ni Z, Cheng W, Yu J, Sun S, Zhai D, et al. Characteristic gut microbiota and predicted metabolic functions in women with PCOS. Endocr Connect. 2020;9:63–73. https://doi.org/10.1530/EC-19-0522 . Lindheim L, Bashir M, Münzker J, Trummer C, Zachhuber V, Leber B, et al. Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study. PLoS ONE. 2017;12:e0168390. https://doi.org/10.1371/journal.pone.0168390 . Liu R, Zhang C, Shi Y, Zhang F, Li L, Wang X, et al. Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome. Front Microbiol. 2017;8:324. https://doi.org/10.3389/fmicb.2017.00324 . Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG. Using published data in Mendelian randomization a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015;30:543–52. https://doi.org/10.1007/s10654-015-0011-z . Ata B, Yildiz S, Turkgeldi E, Brocal VP, Dinleyici EC, Moya A, et al. The Endobiota Study Comparison of Vaginal, Cervical and Gut Microbiota Between Women with Stage 3/4 Endometriosis and Healthy Controls. Sci Rep. 2019;9:2204. https://doi.org/10.1038/s41598-019-39700-6 . Shan J, Ni Z, Cheng W, Zhou L, Zhai D, Sun S, et al. Gut microbiota imbalance and its correlations with hormone and inflammatory factors in patients with stage 3/4 endometriosis. Arch Gynecol Obstet. 2021;304:1363–73. https://doi.org/10.1007/s00404-021-06057-z . Wu J, Zhuo Y, Liu Y, Chen Y, Ning Y, Yao J. Association between premature ovarian insufficiency and gut microbiota. BMC Pregnancy Childbirth. 2021;21:418. https://doi.org/10.1186/s12884-021-03855-w . Hu X, Xu X, Zeng X, Jin R, Wang S, Jiang H, et al. Gut microbiota dysbiosis promotes the development of epithelial ovarian cancer via regulating Hedgehog signaling pathway. Gut Microbes. 2023;15:2221093. https://doi.org/10.1080/19490976.2023.2221093 . Lynch SV, Pedersen O. The Human Intestinal Microbiome in Health and Disease. NEJM. 2016;375:2369–79. https://doi.org/10.1056/NEJMra1600266 . Evans DM, Davey Smith G. Mendelian Randomization New Applications in the Coming Age of Hypothesis-Free Causality. Annu Rev Genomics Hum Genet. 2015;16:327–50. https://doi.org/10.1146/annurev-genom-090314-050016 . Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey Smith G. Mendelian randomization using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27:1133–63. https://doi.org/10.1002/sim.3034 . Kurilshikov A, Medina-Gomez C, Bacigalupe R, Radjabzadeh D, Wang J, Demirkan A, et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet. 2021;53:156–65. https://doi.org/10.1038/s41588-020-00763-1 . Sekula P, Del Greco MF, Pattaro C, Köttgen A. Mendelian Randomization as an Approach to Assess Causality Using Observational Data. J Am Soc Nephrol. 2016;27:3253–65. https://doi.org/10.1681/ASN.2016010098 . Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016;40:304–14. https://doi.org/10.1002/gepi.21965 . Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512–25. https://doi.org/10.1093/ije/dyv080 . Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693–8. https://doi.org/10.1038/s41588-018-0099-7 . Greco MFD, Minelli C, Sheehan NA, Thompson JR. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat Med. 2015;34:2926–40. https://doi.org/10.1002/sim.6522 . Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32:377–89. https://doi.org/10.1007/s10654-017-0255-x . Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies a guide, glossary, and checklist for clinicians. BMJ. 2018;12:362. https://doi.org/10.1136/bmj.k601 . Qi X, Yun C, Sun L, Xia J, Wu Q, Wang Y, et al. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome. Nat Med. 2019;25:1225–33. https://doi.org/10.1038/s41591-019-0509-0 . Yang Y-Y, Pereyra LP, Young RB, Reardon KF, Borch T. Testosterone-mineralizing culture enriched from swine manure characterization of degradation pathways and microbial community composition. Environ Sci Technol. 2011;45:6879–86. https://doi.org/10.1021/es2013648 . Insenser M, Murri M, Del Campo R, Martínez-García MÁ, Fernández-Durán E, Escobar-Morreale HF. Gut Microbiota and the Polycystic Ovary Syndrome Influence of Sex, Sex Hormones, and Obesity. J Clin Endocrinol Metab. 2018;103:2552–62. https://doi.org/10.1210/jc.2017-02799 . Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BAH, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016;535:376–81. https://doi.org/10.1038/nature18646 . Mu H-N, Zhou Q, Yang R-Y, Tang W-Q, Li H-X, Wang S-M, et al. Caffeic acid prevents non-alcoholic fatty liver disease induced by a high-fat diet through gut microbiota modulation in mice. Food Res Int. 2021;143:110240. https://doi.org/10.1016/j.foodres.2021.110240 . Miller TL, Wolin MJ. Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora. Appl Environ Microbiol. 1996;62:1589–92. https://doi.org/10.1128/aem.62.5.1589-1592.1996 . Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7:189–200. https://doi.org/10.1128/aem.62.5.1589-1592.1996 . Hernández MAG, Canfora EE, Jocken JWE, Blaak EE. The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity. Nutrients. 2019;11:1943. https://doi.org/10.3390/nu11081943 . de Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell. 2014;156:84–96. https://doi.org/10.1016/j.cell.2013.12.016 . Barrett HL, Gomez-Arango LF, Wilkinson SA, McIntyre HD, Callaway LK, Morrison M, et al. A Vegetarian Diet Is a Major Determinant of Gut Microbiota Composition in Early Pregnancy. Nutrients. 2018;10:890. https://doi.org/10.3390/nu10070890 . Gomez-Arango LF, Barrett HL, Wilkinson SA, Callaway LK, McIntyre HD, Morrison M, et al. Low dietary fiber intake increases Collinsella abundance in the gut microbiota of overweight and obese pregnant women. Gut Microbes. 2018;9:189–201. https://doi.org/10.1080/19490976.2017.1406584 . Cunha NBd, Ribeiro CT, Silva CM, Rosa-E-Silva ACJdS, De-Souza DA. Dietary intake, body composition and metabolic parameters in women with polycystic ovary syndrome. Clin Nutr. 2019;38:2342–8. https://doi.org/10.1016/j.clnu.2018.10.012 . Zhou J, Zuo W, Tan Y, Wang X, Zhu M, Zhang H. Effects of n-3 polyunsaturated fatty acid on metabolic status in women with polycystic ovary syndrome a meta-analysis of randomized controlled trials. J Ovarian Res. 2023;16:54. https://doi.org/10.1186/s13048-023-01130-4 . Kivenson V, Giovannoni SJ. An Expanded Genetic Code Enables Trimethylamine Metabolism in Human Gut Bacteria. mSystems. 2020;5:e00413–20. https://doi.org/10.1128/mSystems.00413-20 . Elgart M, Stern S, Salton O, Gnainsky Y, Heifetz Y, Soen Y. Impact of gut microbiota on the fly's germ line. Nat Commun. 2016;7:11280. https://doi.org/10.1038/ncomms11280 . Mukherjee A, Lordan C, Ross RP, Cotter PD. Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health. Gut Microbes. 2020;12:1802866. https://doi.org/10.1080/19490976.2020.1802866 . Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol. 2014;14:667–85. https://doi.org/10.1038/nri3738 . Corrêa-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MAR. Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunol. 2016;13:461–72. https://doi.org/10.1038/cti.2016.17 . Petríková J, Lazúrová I. Ovarian failure and polycystic ovary syndrome. Autoimmun Rev. 2012;11:A471–8. https://doi.org/10.1016/j.autrev.2011.11.010 . Ebrahimi M, Akbari Asbagh F. The role of autoimmunity in premature ovarian failure. Iran J Reprod Med. 2015;13:461–72. Jiao X, Zhang H, Ke H, Zhang J, Cheng L, Liu Y, et al. Premature Ovarian Insufficiency Phenotypic Characterization Within Different Etiologies. J Clin Endocrinol Metab. 2017;102:2281–90. https://doi.org/10.1210/jc.2016-3960 . Liu K, Zou J, Fan H, Hu H, You Z. Causal effects of gut microbiota on diabetic retinopathy A Mendelian randomization study. Front Immunol. 2022;13:930318. https://doi.org/10.3389/fimmu.2022.930318 . Fu Z-d, Wang Y, Yan H-L. Male infertility risk and gut microbiota a Mendelian randomization study. Front Microbiol. 2023;14:1228693. https://doi.org/10.3389/fmicb.2023.1228693 . Ye X, Liu B, Bai Y, Cao Y, Lin S, Lyu L, et al. Genetic evidence strengthens the bidirectional connection between gut microbiota and periodontitis insights from a two-sample Mendelian randomization study. J Transl Med. 2023;21:674. https://doi.org/10.1186/s12967-023-04559-9 . Chen J-H, Zeng L-Y, Zhao Y-F, Tang H-X, Lei H, Wan Y-F, et al. Causal effects of gut microbiota on sepsis a two-sample Mendelian randomization study. Front Microbiol. 2023;14:1167416. https://doi.org/10.3389/fmicb.2023.1167416 . Zubrzycka A, Zubrzycki M, Perdas E, Zubrzycka M. Genetic, Epigenetic, and Steroidogenic Modulation Mechanisms in Endometriosis. J Clin Med. 2020;9:1309. https://doi.org/10.3390/jcm9051309 . Ervin SM, Li H, Lim L, Roberts LR, Liang X, Mani S, et al. Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens. J Biol Chem. 2019;294:18586–99. https://doi.org/10.1074/jbc.RA119.010950 . Baker JM, Al-Nakkash L, Herbst-Kralovetz MM. Estrogen-gut microbiome axis Physiological and clinical implications. Maturitas. 2017;103:45–53. https://doi.org/10.1016/j.maturitas.2017.06.02 . Khan KN, Kitajima M, Hiraki K, Yamaguchi N, Katamine S, Matsuyama T, et al. Escherichia coli contamination of menstrual blood and effect of bacterial endotoxin on endometriosis. Fertil Steril. 2010;94:2860–3. https://doi.org/10.1016/j.fertnstert.2010.04.053 . .e1-3. Giudice E, Salutari V, Ricci C, Nero C, Carbone MV, Ghizzoni V, et al. Gut microbiota and its influence on ovarian cancer carcinogenesis, anticancer therapy and surgical treatment A literature review. Crit Rev Oncol Hematol. 2021;168:103542. https://doi.org/10.1016/j.critrevonc.2021.103542 . Xu S, Liu Z, Lv M, Chen Y, Liu Y. Intestinal dysbiosis promotes epithelial-mesenchymal transition by activating tumor-associated macrophages in ovarian cancer. Pathog Dis. 2019;77:ftz019. https://doi.org/10.1093/femspd/ftz019 . Zhu Y, Li Y, Liu M, Hu X, Zhu H. Guizhi Fuling Wan, Chinese Herbal Medicine, Ameliorates Insulin Sensitivity in PCOS Model Rats With Insulin Resistance via Remodeling Intestinal Homeostasis. Front Endocrinol (Lausanne). 2020;11:575. https://doi.org/10.3389/fendo.2020.00575 . Gebeyew K, Chen K, Wassie T, Azad MAK, He J, Jiang W, et al. Dietary Amylose/Amylopectin Ratio Modulates Cecal Microbiota and Metabolites in Weaned Goats. Front Nutr. 2021;8:774766. https://doi.org/10.3389/fnut.2021.774766 . Wenzel TJ, Gates EJ, Ranger AL, Klegeris A. Short-chain fatty acids (SCFAs) alone or in combination regulate select immune functions of microglia-like cells. Mol Cell Neurosci. 2020;105:103493. https://doi.org/10.1016/j.mcn.2020.103493 . Additional Declarations No competing interests reported. Supplementary Files SupplementaryMaterial.zip Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-4188266","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":285529390,"identity":"4d2b0b93-ec8c-4b23-ab2e-8595fdf9b598","order_by":0,"name":"Xueying Liu","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA00lEQVRIiWNgGAWjYBACPjBpwJDAwMB84MCHH0RoYUNoYUs8OLOHaC0MIC08xoc52PCphWmRyDH78KPgTh6/RM6Hwww8DPL8YgcIaOE5Yzyzx+BZseSM3A2HCywYDGfOTiCghb3HmIHH4HDihttALTN4GBIMbhPSwsxjzPgHrCXnwWEeNmK0AG1hhtiSw0CkFp5jxcwyBoeLJec/MwAGsgRhv/BLJG9mfPPncB4/z+HHHz78sJHnlyaghYGBwwCZJ0FIOQiwPyBG1SgYBaNgFIxkAAA0w0MhpSLhFwAAAABJRU5ErkJggg==","orcid":"","institution":"Reproductive Medicine Center, International Institutes of Medicine, the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang","correspondingAuthor":true,"submittingAuthor":false,"prefix":"","firstName":"Xueying","middleName":"","lastName":"Liu","suffix":""},{"id":285529391,"identity":"e07cf9ca-66f6-4351-86d6-c7611ddae0fe","order_by":1,"name":"Kejing Zhu","email":"","orcid":"","institution":"Reproductive Medicine Center, International Institutes of Medicine, the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Kejing","middleName":"","lastName":"Zhu","suffix":""},{"id":285529392,"identity":"bf116b73-55a6-45a3-b0d3-b26e780cca7f","order_by":2,"name":"Renke He","email":"","orcid":"","institution":"Reproductive Medicine Center, International Institutes of Medicine, the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Renke","middleName":"","lastName":"He","suffix":""},{"id":285529393,"identity":"e962e517-26e3-4f67-b0f9-f93ba0bd2a56","order_by":3,"name":"Zhaoying Jiang","email":"","orcid":"","institution":"Reproductive Medicine Center, International Institutes of Medicine, the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Zhaoying","middleName":"","lastName":"Jiang","suffix":""},{"id":285529394,"identity":"f9525e5a-fbe3-4f34-89ad-80984e613568","order_by":4,"name":"Haiyan Wu","email":"","orcid":"","institution":"Key Laboratory of Reproductive Genetics (Ministry of Education), Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Haiyan","middleName":"","lastName":"Wu","suffix":""},{"id":285529395,"identity":"ea965725-c5c4-4bbc-b407-c3efd5d61a07","order_by":5,"name":"Jiaen Yu","email":"","orcid":"","institution":"Key Laboratory of Reproductive Genetics (Ministry of Education), Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Jiaen","middleName":"","lastName":"Yu","suffix":""},{"id":285529396,"identity":"5812a7b5-4cb4-41af-a155-325acf8d6d7b","order_by":6,"name":"Qinyu Luo","email":"","orcid":"","institution":"Key Laboratory of Reproductive Genetics (Ministry of Education), Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Qinyu","middleName":"","lastName":"Luo","suffix":""},{"id":285529397,"identity":"1fbcfb12-2222-45d1-b83c-7b6f15441397","order_by":7,"name":"Jianzhong Sheng","email":"","orcid":"","institution":"Reproductive Medicine Center, International Institutes of Medicine, the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Jianzhong","middleName":"","lastName":"Sheng","suffix":""},{"id":285529398,"identity":"8cb527b2-082a-4e32-9d19-9645908d4065","order_by":8,"name":"Jiexue Pan","email":"","orcid":"","institution":"Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Jiexue","middleName":"","lastName":"Pan","suffix":""},{"id":285529399,"identity":"5955f27f-c28d-445f-85aa-b4d0765fa1f6","order_by":9,"name":"Hefeng Huang","email":"","orcid":"","institution":"Reproductive Medicine Center, International Institutes of Medicine, the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Hefeng","middleName":"","lastName":"Huang","suffix":""},{"id":285529400,"identity":"08ecc0c9-f0dd-4383-a7bc-8990f0e04017","order_by":10,"name":"Zhongliang Lin","email":"","orcid":"","institution":"Reproductive Medicine Center, International Institutes of Medicine, the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Zhongliang","middleName":"","lastName":"Lin","suffix":""}],"badges":[],"createdAt":"2024-03-29 13:50:05","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-4188266/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-4188266/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":54046571,"identity":"eb91aa3f-c07d-4a55-95ac-e60dc393ae38","added_by":"auto","created_at":"2024-04-03 19:31:41","extension":"png","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":161132,"visible":true,"origin":"","legend":"\u003cp\u003eStudy design (a) Flowchart showing the process for the MR analyses, including data collection, IVs selection, and statistical analysis. (b) Directed acyclic graph showing the assumptions of the MR methodology. MR relies on three assumptions: the genetic variants selected as instruments must (1) be associated with the exposure, (2) not be associated with confounders, (3) not directly affect the outcome, except through their effect on the exposure\u003c/p\u003e","description":"","filename":"Fig.1.png","url":"https://assets-eu.researchsquare.com/files/rs-4188266/v1/c42cfdfdf010420b2a5c9f24.png"},{"id":54046570,"identity":"015dea74-16d6-409e-b932-de14835a15d0","added_by":"auto","created_at":"2024-04-03 19:31:41","extension":"png","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":482680,"visible":true,"origin":"","legend":"\u003cp\u003eMendelian randomization analyses of the effect of the gut microbiome on the risk of ovarian diseases\u003c/p\u003e","description":"","filename":"Fig.2.png","url":"https://assets-eu.researchsquare.com/files/rs-4188266/v1/75771886bbb8d0b097610342.png"},{"id":56144309,"identity":"96983937-0570-497a-a57d-8bf5e6dc6926","added_by":"auto","created_at":"2024-05-09 05:13:29","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1328560,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-4188266/v1/328b634e-cbec-48fe-97ae-9eede6c9410f.pdf"},{"id":54046572,"identity":"bfe226ca-2427-46be-9d5f-cb1d8aa82448","added_by":"auto","created_at":"2024-04-03 19:31:41","extension":"zip","order_by":3,"title":"","display":"","copyAsset":false,"role":"supplement","size":3401472,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryMaterial.zip","url":"https://assets-eu.researchsquare.com/files/rs-4188266/v1/ba7ccf40727886a3bd36c6e7.zip"}],"financialInterests":"No competing interests reported.","formattedTitle":"Gut microbiota and risk of ovarian diseases: a two-sample Mendelian randomization study","fulltext":[{"header":"1. Introduction","content":"\u003cp\u003eThe ovary is essential for establishing and maintaining secondary sexual characteristics and fertility in females. However, ovarian diseases, such as polycystic ovary syndrome (PCOS), premature ovarian failure (POF), ovarian endometriosis and ovarian neoplasm, negatively influence reproductive health and induce disorders of ovarian function. PCOS is one of the most common reproductive endocrine and metabolic disorders, and common signs of PCOS are ovulatory dysfunction, excess androgen exposure and the presence of polycystic ovaries, which can impair fertility [\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e]. POF refers to the exhaustion of the ovarian reserve before the age of 40 years. Given that the chance of spontaneous conception is 5%-10% [\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e],adoption or in vitro fertilization and embryo transfer using donor oocytes are considered effective fertility treatments for women with POF. Radiotherapy, chemotherapy, and pelvic surgery for malignant and benign conditions, including ovarian endometriomas and ovarian cancer, can negatively affect the ovarian reserve [\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e, \u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e] and even lead to POF [\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e]. Unfortunately, the potential causes and molecular mechanisms of these ovarian diseases have not yet been elucidated.\u003c/p\u003e \u003cp\u003eMore recently, the gastrointestinal tract, which hosts ten trillion diverse symbionts (50 bacterial phyla and approximately 100\u0026ndash;1000 bacterial species), has been extensively studied owing to its basic functions in the immunological, metabolic, structural and neurological landscapes in humans [\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e]. Recent research has shown that the interaction of the female reproductive endocrine system with estrogen, androgens, insulin, and other hormones appears to be crucial for successful pregnancy [\u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e]. Several observational studies have suggested that an imbalance in gut microbiota stabilization may induce PCOS [\u003cspan additionalcitationids=\"CR8 CR9\" citationid=\"CR7\" class=\"CitationRef\"\u003e7\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e], endometriosis [\u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e, \u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e12\u003c/span\u003e], ovarian dysfunction [\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e] and ovarian cancer [\u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e] in women. However, less is known about the exact role of the gut microbiota in ovarian physiology, and few studies have explored the causal relationship between the gut microbiota and certain diseases [\u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eEstablishing the causal relationship between specific gut bacteria and certain ovarian diseases would be highly valuable for the prevention and treatment of this disease. Although randomized controlled trials (RCTs) are the gold standard for establishing causal relationships, they can be costly, time-consuming and even impractical [\u003cspan citationid=\"CR16\" class=\"CitationRef\"\u003e16\u003c/span\u003e]. On the other hand, observational studies may not robustly reflect causal relationships owing to many potential biases, confounders and reverse causation [\u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e17\u003c/span\u003e]. Mendelian randomization (MR) is an approach that uses genetic variants associated with an exposure as instrumental variables (IVs) to examine the causality of exposure\u0026ndash;outcome associations. MR can minimize potential confounders and reverse causality as genetic variants segregate randomly and independently and precede the outcome of interest [\u003cspan citationid=\"CR16\" class=\"CitationRef\"\u003e16\u003c/span\u003e]. Furthermore, during the last decade, the publication of a large volume of genome-wide association studies (GWASs) has led to the conduction of MR studies without the need to recruit new patients. Therefore, MR offers a suitable means to infer the causal effect between the gut microbiota and the risk of ovarian disease. Here, we implemented bidirectional MR analyses to explore the causal relationship between the gut microbiota and ovarian diseases.\u003c/p\u003e"},{"header":"2. Materials and Methods","content":"\u003cp\u003eWe assessed the causal links between the gut microbiota and five ovarian diseases using two-sample MR. An overview of the analytical approach is shown in Fig.\u0026nbsp;\u003cspan refid=\"Fig1\" class=\"InternalRef\"\u003e1\u003c/span\u003ea.\u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003cdiv id=\"Sec3\" class=\"Section2\"\u003e \u003ch2\u003e2.1 Exposure data\u003c/h2\u003e \u003cp\u003eWe obtained genetic variant information related to the human gut microbiome composition from the latest large-scale genome-wide meta-analysis conducted by the MiBioGen consortium (\u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://mibiogen.gcc.rug.nl/\u003c/span\u003e\u003cspan address=\"https://mibiogen.gcc.rug.nl/\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.) based on European-dominated participants [\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e]. This study analyzed genome-wide genotypes and 16S fecal microbiome data from 18,340 individuals from 24 cohorts. Accordingly, the genus level was the lowest. A total of 131 genera with a mean abundance greater than 1% were identified, 12 of which were unknown genera [\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e]. As a result, we included 119 genus-level taxa in the present study.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec4\" class=\"Section2\"\u003e \u003ch2\u003e2.2 Outcome data\u003c/h2\u003e \u003cp\u003eWe obtained genetic variants related to the human gut microbiome composition from the latest large-scale genome-wide meta-analysis conducted by the MiBioGen consortium. https//mibiogen.gcc.rug.nl/.) based on European-dominated participants [\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e]. This study analyzed genome-wide genotype and 16S fecal microbiome data from 18,340 individuals from 24 cohorts. Accordingly, the genus level was the lowest. A total of 131 genera with a mean abundance greater than 1% were identified, 12 of which were unknown genera [\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e]. As a result, we included 119 genus-level taxa in the present study.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec5\" class=\"Section2\"\u003e \u003ch2\u003e2.3 Instrumental variable selection\u003c/h2\u003e \u003cp\u003eSingle-nucleotide polymorphisms (SNPs) are used as IVs in MR analysis to provide evidence of causality between an exposure and outcome. To ensure the accuracy and robustness of the causal link, SNPs must satisfy three core assumptions to be used as IVs (Fig.\u0026nbsp;\u003cspan refid=\"Fig1\" class=\"InternalRef\"\u003e1\u003c/span\u003eb) [\u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e19\u003c/span\u003e]. Therefore, the following steps were conducted. First, we selected independent SNPs (linkage disequilibrium \u003cem\u003eR\u003c/em\u003e\u003csup\u003e\u003cem\u003e2\u003c/em\u003e\u003c/sup\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.001 and clumping distance\u0026thinsp;=\u0026thinsp;10,000 kb, based on the European-based 1000 Genome Projects reference panel) associated with each genus at a locus-wide threshold of significance (\u003cem\u003eP\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;1\u0026times; 10\u003csup\u003e\u0026minus;\u0026thinsp;5\u003c/sup\u003e). Second, the minor allele frequency (MAF) threshold of the variants of interest was 0.01. Third, allele frequency information was used to infer that palindromic SNPs were aligned in the same direction for exposure and outcome.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec6\" class=\"Section2\"\u003e \u003ch2\u003e2.4 Statistical analysis\u003c/h2\u003e \u003cp\u003eThe inverse variance weighted (IVW) method was used as the primary statistical method and can provide the most accurate causal estimates provided that the pleiotropic effect is balanced and that all IVs meet the MR assumptions [\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e]. Since it is difficult to verify that IVs influence the outcome only through the exposure of interest, we performed a series of sensitivity analyses with different assumptions to assess the robustness of the associations and to examine horizontal pleiotropy for exposures, including weighted median, MR‒Egger simple mode weighted mode and MR pleiotropy residual sum and outlier (MR-PRESSO) analyses. The weighted median of SNP-specific estimates provides valid estimates when more than 50% of the information is contributed from the IVs [\u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e20\u003c/span\u003e]. MR-Egger regression provides a valid estimate of causal estimates under the instrument strength independent of direct effect (InSIDE) assumption [\u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e]. However, this approach was used to detect and adjust for unbalanced horizontal pleiotropy rather than to produce causal estimates due to the low statistical power of MR-Egger. A MR-Egger intercept significantly different from 0 (\u003cem\u003eP\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.05) indicated the occurrence of directional pleiotropy and a potentially biased IVW estimate. In addition, horizontal pleiotropy was also assessed by employing the MR-PRESSO global test, and where evident, the MR‐PRESSO outlier test was used to exclude outlying SNPs and correct the IVW estimate [\u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e]. To further test the robustness of our results, Cochran\u0026rsquo;s Q test was used to evaluate heterogeneity among the SNPs included in each analysis. Q statistics significant at \u003cem\u003eP\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.05 provide evidence for heterogeneity between individual genetic variants and the existence of invalid instruments [\u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e23\u003c/span\u003e]. In addition, leave-one-out analysis was performed to assess whether an outcome was driven by a single outlying SNP [\u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e], indicating the presence of heterogeneous SNPs. Furthermore, if the genetic variants do not explain enough of the variance, there will be significant weak instrumental bias toward the confounded estimate [\u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e]. To address this concern, SNP\u0026ndash;specific F-statistics, approximated by the square of the beta divided by the variance for the SNP\u0026ndash;exposure association, were calculated to evaluate the strength of the instruments used, and values exceeding the standard threshold of 10 are indicative of strong genetic instruments [\u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e]. To explore whether ovarian diseases have any causal impact on the bacterial genera that were found to be causally associated with ovarian diseases in forward MR analysis, we also performed a reverse MR analysis using SNPs that are associated with each ovarian disease at a threshold smaller than the locus-wide significance level (5 \u0026times; 10\u003csup\u003e\u0026minus;\u0026thinsp;6\u003c/sup\u003e) as IVs.\u003c/p\u003e \u003cp\u003eAll tests were two-sided and performed using R Version 4.2.1 with the R packages \u0026ldquo;TwoSampleMR\u0026rdquo;, \u0026ldquo;MendelianRandomization\u0026rdquo; and \u0026ldquo;MR-PRESSO\u0026rdquo;. A \u003cem\u003eP\u003c/em\u003e value\u0026thinsp;\u0026lt;\u0026thinsp;0.05 indicated statistical significance of the MR effect estimate. No ethical approval was required since we used publicly available summary data.\u003c/p\u003e \u003c/div\u003e"},{"header":"3. Results","content":"\u003cdiv id=\"Sec8\" class=\"Section2\"\u003e \u003ch2\u003e3.1 SNP selection\u003c/h2\u003e \u003cp\u003eThere were 1508 SNPs selected for the MR analyses according to the IV selection criteria. The detailed information and F-statistic for the selected instruments are shown in Supplementary Table\u0026nbsp;2. The overall instrument had a high F-statistic (\u0026gt;\u0026thinsp;10), indicating the good strength of the genetic instruments used.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec9\" class=\"Section2\"\u003e \u003ch2\u003e3.2 Causal effects of the gut microbiome on ovarian diseases\u003c/h2\u003e \u003cp\u003eFigure\u0026nbsp;\u003cspan refid=\"Fig2\" class=\"InternalRef\"\u003e2\u003c/span\u003e shows causal effect estimates of the gut microbiota on PCOS, POF, ovarian endometriosis, and ovarian neoplasm from the IVW MR analyses. Associations for individual SNPs using the different MR methods are presented in Supplementary Table\u0026nbsp;3\u0026ndash;7. Scatter and forest plots of the SNP-outcome associations against the SNP-exposure associations are shown in Supplementary Figs.\u0026nbsp;1\u0026ndash;10, allowing visualization of the causal effect estimate for each individual SNP on PCOS, POF, ovarian endometriosis, and ovarian neoplasm. Leave-one-out plots are shown in Supplementary Fig.\u0026nbsp;11\u0026ndash;15 to evaluate the influential outliers.\u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003cdiv id=\"Sec10\" class=\"Section3\"\u003e \u003ch2\u003e3.2.1 PCOS\u003c/h2\u003e \u003cp\u003eMR analysis via the IVW method showed that \u003cem\u003eBarnesiella\u003c/em\u003e, \u003cem\u003eBilophila\u003c/em\u003e, and \u003cem\u003eHoldemania\u003c/em\u003e were negatively associated with the risk of PCOS odds ratio (OR)\u0026thinsp;=\u0026thinsp;0.55, 95%Cl, 0.36\u0026ndash;0.84, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.005; OR\u0026thinsp;=\u0026thinsp;0.58, 95%Cl, 0.37\u0026ndash;0.92, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.021; OR\u0026thinsp;=\u0026thinsp;0.64, 95%Cl, 0.47\u0026ndash;0.88, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.005 (Fig.\u0026nbsp;\u003cspan refid=\"Fig2\" class=\"InternalRef\"\u003e2\u003c/span\u003e). According to the reverse MR analysis by the IVW method, no significant causal association was found between PCOS and these three bacterial genera (Supplementary Table\u0026nbsp;18).\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec11\" class=\"Section3\"\u003e \u003ch2\u003e3.2.2 POF\u003c/h2\u003e \u003cp\u003eMR analysis via the IVW method revealed that \u003cem\u003eEubacterium (hallii group)\u003c/em\u003e and \u003cem\u003eEubacterium (ventriosum group)\u003c/em\u003e were negatively associated with the risk of POF (OR\u0026thinsp;=\u0026thinsp;0.49, 95% Cl, 0.26\u0026ndash;0.90, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.022; OR\u0026thinsp;=\u0026thinsp;0.51, 95% Cl, 0.27\u0026ndash;0.97, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.040), while \u003cem\u003eAdlercreutzia\u003c/em\u003e, \u003cem\u003eIntestinibacter\u003c/em\u003e, \u003cem\u003eLachnospiraceae (UCG008)\u003c/em\u003e, and \u003cem\u003eTerrisporobacter\u003c/em\u003e were positively associated with the risk of POF (OR\u0026thinsp;=\u0026thinsp;3.01, 95% Cl, 1.38\u0026ndash;6.60, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.006; OR\u0026thinsp;=\u0026thinsp;1.82, 95% Cl, 1.04\u0026ndash;3.20, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.037; OR\u0026thinsp;=\u0026thinsp;1.73, 95% Cl, 1.08\u0026ndash;2.76, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.023; OR\u0026thinsp;=\u0026thinsp;2.47, 95% Cl, 1.14\u0026ndash;5.36, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.022) (Fig.\u0026nbsp;\u003cspan refid=\"Fig2\" class=\"InternalRef\"\u003e2\u003c/span\u003e). According to the reverse MR analysis by the IVW method, no significant causal association was found between POF and these six bacterial genera (Supplementary Table\u0026nbsp;19).\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec12\" class=\"Section3\"\u003e \u003ch2\u003e3.2.3 Ovarian endometriosis\u003c/h2\u003e \u003cp\u003eMR analysis via the IVW method showed that \u003cem\u003eIntestinimonas\u003c/em\u003e was positively associated with the risk of ovarian endometriosis (OR\u0026thinsp;=\u0026thinsp;1.21, 95% Cl, 1.03\u0026ndash;1.42, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.018), while \u003cem\u003eRikenellaceae\u003c/em\u003e (\u003cem\u003eRC9gut group)\u003c/em\u003e and \u003cem\u003eRuminococcaceae (UCG013)\u003c/em\u003e were negatively associated with the risk of ovarian endometriosis (OR\u0026thinsp;=\u0026thinsp;0.88, 95% Cl, 0.80\u0026ndash;0.98, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.017; OR\u0026thinsp;=\u0026thinsp;0.78, 95% Cl, 0.63\u0026ndash;0.98, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.030) (Fig.\u0026nbsp;\u003cspan refid=\"Fig2\" class=\"InternalRef\"\u003e2\u003c/span\u003e). According to the reverse MR analysis by the IVW method, no significant causal association was found between ovarian endometriosis and these three bacterial genera (Supplementary Table\u0026nbsp;20).\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec13\" class=\"Section3\"\u003e \u003ch2\u003e3.2.4 Benign ovarian neoplasm\u003c/h2\u003e \u003cp\u003eMR analysis via the IVW method revealed that \u003cem\u003eEubacterium (nodatum group)\u003c/em\u003e was positively associated with the risk of benign ovarian neoplasm (OR\u0026thinsp;=\u0026thinsp;1.15, 95% Cl, 1.01\u0026ndash;1.31, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.039), while \u003cem\u003eRuminococcus (torques group)\u003c/em\u003e, \u003cem\u003eBarnesiella\u003c/em\u003e, and \u003cem\u003eBlautia\u003c/em\u003e were negatively associated with the risk of benign ovarian neoplasm (OR\u0026thinsp;=\u0026thinsp;0.65, 95% Cl, 0.48\u0026ndash;0.88, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.006; OR\u0026thinsp;=\u0026thinsp;0.79, 95% Cl, 0.63\u0026ndash;0.99, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.038; OR\u0026thinsp;=\u0026thinsp;0.78, 95% Cl, 0.62\u0026ndash;1.00, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.046) (Fig.\u0026nbsp;\u003cspan refid=\"Fig2\" class=\"InternalRef\"\u003e2\u003c/span\u003e). According to the reverse MR analysis by the IVW method, no significant causal associations were found between benign ovarian neoplasms and these four bacterial genera (Supplementary Table\u0026nbsp;21).\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec14\" class=\"Section3\"\u003e \u003ch2\u003e3.2.5 Malignant ovarian neoplasms\u003c/h2\u003e \u003cp\u003eMR analysis via the IVW method revealed that \u003cem\u003eLachnospiraceae (UCG008)\u003c/em\u003e and \u003cem\u003eRuminococcaceae (UCG011)\u003c/em\u003e were positively associated with the risk of malignant ovarian neoplasms (OR\u0026thinsp;=\u0026thinsp;1.44, 95% Cl, 1.10\u0026ndash;1.90, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.009; OR\u0026thinsp;=\u0026thinsp;1.35, 95% Cl, 1.01\u0026ndash;1.80, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.039), while \u003cem\u003eParaprevotella\u003c/em\u003e, \u003cem\u003eRuminococcaceae (UCG005)\u003c/em\u003e, \u003cem\u003eSenegalimassilia\u003c/em\u003e, and \u003cem\u003eSlackia\u003c/em\u003e were negatively associated with the risk of malignant ovarian neoplasms (OR\u0026thinsp;=\u0026thinsp;0.72, 95% Cl, 0.54\u0026ndash;0.95, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.022; OR\u0026thinsp;=\u0026thinsp;0.64, 95% Cl, 0.45\u0026ndash;0.92, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.016; OR\u0026thinsp;=\u0026thinsp;0.59, 95% Cl, 0.36\u0026ndash;0.94, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.029; OR\u0026thinsp;=\u0026thinsp;0.66, 95% Cl, 0.44\u0026ndash;0.98, \u003cem\u003eP\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.039) (Fig.\u0026nbsp;\u003cspan refid=\"Fig2\" class=\"InternalRef\"\u003e2\u003c/span\u003e). According to the reverse MR analysis by the IVW method, no significant causal association was found between malignant ovarian neoplasms and these six bacterial genera (Supplementary Table\u0026nbsp;22).\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec15\" class=\"Section3\"\u003e \u003ch2\u003e3.2.6 Sensitivity analyses\u003c/h2\u003e \u003cp\u003eThe observed causal associations were consistent in sensitivity analyses. There was no evidence of significant heterogeneity or directional pleiotropy using Cochran\u0026rsquo;s Q test, MR Egger intercepts or MR-PRESSO in our study (Table\u0026nbsp;\u003cspan refid=\"Tab1\" class=\"InternalRef\"\u003e1\u003c/span\u003e and Supplementary Table\u0026nbsp;8\u0026ndash;12). No outliers were visually inspected in either the scatter (Supplementary Figs.\u0026nbsp;1\u0026ndash;5) or forest plots (Supplementary Figs.\u0026nbsp;6\u0026ndash;10). Furthermore, the leave-one-out analysis suggested that the observed associations remained consistent after eliminating each single SNP at a time (Supplementary Figs.\u0026nbsp;11\u0026ndash;15), suggesting the robustness of the results.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab1\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 1\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eHeterogeneity and directional pleiotropy tests from MR analysis of the gut microbiota and risk of ovarian diseases.\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"9\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c7\" colnum=\"7\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c8\" colnum=\"8\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c9\" colnum=\"9\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eOutcome\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eExposure\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e \u003cp\u003eHeterogeneity\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"3\" nameend=\"c7\" namest=\"c5\"\u003e \u003cp\u003eMR‒Egger\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003eMR-PRESSO\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eCochrane\u0026rsquo;s Q\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003eP\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cp\u003eEgger Intercept\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c6\"\u003e \u003cp\u003eSE\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c7\"\u003e \u003cp\u003eP\u003csub\u003eintercept\u003c/sub\u003e\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c8\"\u003e \u003cp\u003eCausal\u003c/p\u003e \u003cp\u003eEstimate\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c9\"\u003e \u003cp\u003eGlobal\u003c/p\u003e \u003cp\u003eTest P\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003ePCOS\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eBarnesiella\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e4.80\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.941\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e-0.01\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.07\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.837\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e-0.60\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.940\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eBilophila\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e15.61\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.210\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e-0.03\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.09\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.704\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e-0.54\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.225\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eHoldemania\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e7.94\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.847\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e-0.01\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.05\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.821\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e-0.44\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.864\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003ePOF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eEubacterium (hallii group)\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e9.01\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.773\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e-0.01\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.05\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.916\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e-0.72\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.795\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eEubacterium (ventriosum group)\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e10.02\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.761\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e-0.02\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.11\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.858\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e-0.68\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.764\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eAdlercreutzia\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e9.55\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.215\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e0.28\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.14\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.085\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e1.10\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.271\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eIntestinibacter\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e12.90\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.535\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e-0.08\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.08\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.307\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e0.60\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.558\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eLachnospiraceae (UCG008)\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e10.44\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.491\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e0.10\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.12\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.446\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e0.55\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.505\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eTerrisporobacter\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e2.93\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.570\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e0.05\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.12\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.703\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e0.90\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.603\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eOvarian endometriosis\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eIntestinimonas\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e10.96\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.756\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e0.02\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.02\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.388\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e0.19\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.756\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eRikenellaceae (RC9gut group)\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e11.01\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.443\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e0.08\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.04\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.092\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e-0.12\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.465\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eRuminococcaceae (UCG013)\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e9.09\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.523\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e-0.01\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.02\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.730\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e-0.24\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.542\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eBenign ovarian neoplasm\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eEubacterium (nodatum group)\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e13.97\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.174\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e-0.05\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.04\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.269\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e0.14\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.200\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eRuminococcus (torques group)\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e5.10\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.647\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e-0.03\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.03\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.351\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e-0.43\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.703\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eBarnesiella\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e12.03\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.362\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e0.04\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.03\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.289\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e-0.24\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.376\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eBlautia\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e10.85\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.456\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e0.03\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.02\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.269\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e-0.24\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.446\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eMalignant ovarian neoplasm\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eLachnospiraceae (UCG008)\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e7.33\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.772\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e0.14\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.07\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.074\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e0.37\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.785\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eParaprevotella\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e14.63\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.262\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e0.02\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.06\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.719\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e-0.33\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.292\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eRuminococcaceae (UCG005)\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e11.76\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.547\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e-0.02\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.04\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.682\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e-0.44\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.592\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eRuminococcaceae (UCG011)\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e9.64\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.210\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e-0.05\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.10\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.668\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e0.30\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.256\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eSenegalimassili\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e1.64\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.801\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e0.07\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.09\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.478\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e-0.54\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.813\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003eSlackia\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e3.52\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e0.620\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e-0.07\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e0.13\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e0.643\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c8\"\u003e \u003cp\u003e-0.42\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c9\"\u003e \u003cp\u003e0.656\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003ePCOS, polycystic ovary syndrome; POF, premature ovarian failure; MR, Mendelian randomization.\u003c/p\u003e \u003c/div\u003e \u003c/div\u003e"},{"header":"4. Discussion","content":"\u003cp\u003eWe conducted MR analyses by using the largest GWAS dataset to systematically investigate the causal relationship between the gut microbiota and the risk of ovarian diseases. Our results showed that there were causal effects of several genetically predicted genera of the gut microbiota on the risk of PCOS, POF, ovarian endometriosis and ovarian neoplasm. The positive or negative relationships between the gut microbiota and certain ovarian diseases were further verified by sensitivity analyses. This study could provide important insight into the genetic relationship between the gut microbiome and ovarian diseases and shed new light on the potential causes and therapeutic strategies for ovarian diseases.\u003c/p\u003e \u003cdiv id=\"Sec17\" class=\"Section2\"\u003e \u003ch2\u003e4.1 The potential role of the gut microbiota in PCOS\u003c/h2\u003e \u003cp\u003eRecent studies have demonstrated that gut microbes play vital roles in the etiology of PCOS [\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e]. In this study, we found that \u003cem\u003eBarnesiella\u003c/em\u003e, \u003cem\u003eBilophila\u003c/em\u003e and \u003cem\u003eHoldemania\u003c/em\u003e had protective effects on PCOS, which has not been demonstrated previously [\u003cspan additionalcitationids=\"CR8\" citationid=\"CR7\" class=\"CitationRef\"\u003e7\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e]. Evidence from other studies has demonstrated that the gut microbiome and its metabolites are involved in the pathogenesis of hyperandrogenaemia and insulin resistance, which are salient features of PCOS [\u003cspan additionalcitationids=\"CR28\" citationid=\"CR27\" class=\"CitationRef\"\u003e27\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e29\u003c/span\u003e]. \u003cem\u003eBarnesiella\u003c/em\u003e was reported to be short-chain fatty acid (SCFA)-producing bacteria [\u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e27\u003c/span\u003e, \u003cspan citationid=\"CR30\" class=\"CitationRef\"\u003e30\u003c/span\u003e]. SCFAs, including propionate, acetate and butyrate, are the main products of the fermentation of dietary fiber by the intestinal microbiota [\u003cspan citationid=\"CR31\" class=\"CitationRef\"\u003e31\u003c/span\u003e]. Butyrate can enhance the expression of tight-junction proteins and mucin to maintain the intestinal epithelial barrier [\u003cspan citationid=\"CR32\" class=\"CitationRef\"\u003e32\u003c/span\u003e], which is the first line of defense in the intestine. On the other hand, SCFAs beneficially affect the metabolic process of the host, especially insulin resistance. Data from human and animal studies have demonstrated that acetate promotes host metabolism and improves insulin sensitivity through the secretion of a gut hormone, which inhibits appetite and reduces lipolysis and systemic proinflammatory cytokine levels [\u003cspan citationid=\"CR33\" class=\"CitationRef\"\u003e33\u003c/span\u003e]. Furthermore, a study suggested that propionate and butyrate activate intestinal gluconeogenesis via complementary mechanisms [\u003cspan citationid=\"CR34\" class=\"CitationRef\"\u003e34\u003c/span\u003e]. Hence, \u003cem\u003eBarnesiella\u003c/em\u003e may reduce the risk of PCOS through the biological functions of SCFAs. Barrett \u003cem\u003eet al.\u003c/em\u003e [\u003cspan citationid=\"CR35\" class=\"CitationRef\"\u003e35\u003c/span\u003e, \u003cspan citationid=\"CR36\" class=\"CitationRef\"\u003e36\u003c/span\u003e] reported that \u003cem\u003eHoldemania\u003c/em\u003e abundance was positively associated with the intake of dietary fiber, overall polyunsaturated fat (PUFA) and both ω-3 and ω-6 PUFAs. In addition, it has been documented that adequate intake of dietary fiber and supplementation with PUFAs are both conducive to improving glucose metabolism and lipid profiles [\u003cspan citationid=\"CR37\" class=\"CitationRef\"\u003e37\u003c/span\u003e, \u003cspan citationid=\"CR38\" class=\"CitationRef\"\u003e38\u003c/span\u003e]. \u003cem\u003eHoldemania\u003c/em\u003e may exert important effects on metabolic status in PCOS patients through the beneficial influence of dietary fiber and PUFAs, but further studies are needed to prove this assumption. Although \u003cem\u003eBilophila\u003c/em\u003e has been shown to mitigate cardiovascular disease by metabolizing both trimethylamine and its precursors without the production of trimethylamine-N-oxide [\u003cspan citationid=\"CR39\" class=\"CitationRef\"\u003e39\u003c/span\u003e], no evidence has been reported for the positive effect of \u003cem\u003eBilophila\u003c/em\u003e on PCOS, and additional in-depth studies are needed to explore the underlying mechanism involved.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec18\" class=\"Section2\"\u003e \u003ch2\u003e4.2 The potential role of the gut microbiota in POF\u003c/h2\u003e \u003cp\u003eAltered gut microbial profiles have been abserved in women with POF [\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e]. Additionally, Elgart \u003cem\u003eet al.\u003c/em\u003e [\u003cspan citationid=\"CR40\" class=\"CitationRef\"\u003e40\u003c/span\u003e] reported that the gut bacteria of Drosophila can affect oogenesis and maternal-to-zygotic transition during embryo development. In this study, we found that \u003cem\u003eEubacterium (hallii group)\u003c/em\u003e and \u003cem\u003eEubacterium (ventriosum group)\u003c/em\u003e had protective effects on POF. \u003cem\u003eEubacterium\u003c/em\u003e produces SCFAs. The abundance of \u003cem\u003eEubacterium\u003c/em\u003e in the gut is strongly correlated with SCFA levels and the beneficial effects of SCFAs under a range of clinical conditions [\u003cspan citationid=\"CR41\" class=\"CitationRef\"\u003e41\u003c/span\u003e].Several studies have shown that SCFAs play a major role in the modulation of inflammation through the inhibition of proinflammatory cytokines, such as interferon (IFN)-γ, interleukin (IL)-1β, IL-6, IL-8, and tumor necrosis factor receptor-α (TNF-α), while upregulating the expression of anti-inflammatory cytokines, such as IL-10 and transforming growth factor-β (TGF-β) [\u003cspan citationid=\"CR42\" class=\"CitationRef\"\u003e42\u003c/span\u003e, \u003cspan citationid=\"CR43\" class=\"CitationRef\"\u003e43\u003c/span\u003e]. The human ovary is a ubiquitous target for autoimmune attack, leading to the consequent occurrence of POF [\u003cspan citationid=\"CR44\" class=\"CitationRef\"\u003e44\u003c/span\u003e]. Autoimmunity is responsible for approximately 4\u0026ndash;30% of POF cases [\u003cspan citationid=\"CR45\" class=\"CitationRef\"\u003e45\u003c/span\u003e, \u003cspan citationid=\"CR46\" class=\"CitationRef\"\u003e46\u003c/span\u003e]. \u003cem\u003eE. hallii\u003c/em\u003e and \u003cem\u003eE. ventriosum\u003c/em\u003e may act as anti-inflammatory agents to protect the ovary from inflammation. On the other hand, we found that \u003cem\u003eAdlercreutzia\u003c/em\u003e, \u003cem\u003eIntestinibacter\u003c/em\u003e, \u003cem\u003eLachnospiraceae (UCG008\u003c/em\u003e), and \u003cem\u003eTerrisporobacter\u003c/em\u003e increased the risk of POF. Other studies have shown that these 4 gut microbiome taxa are correlated with the risk of diabetic retinopathy, male infertility, periodontitis, and sepsis [\u003cspan additionalcitationids=\"CR48 CR49\" citationid=\"CR47\" class=\"CitationRef\"\u003e47\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR50\" class=\"CitationRef\"\u003e50\u003c/span\u003e]. However, there is a lack of corresponding research evidence to clarify the underlying mechanism by which these gut microbiome taxa contribute to POF, thus providing new directions for future studies.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec19\" class=\"Section2\"\u003e \u003ch2\u003e4.3 The potential role of the gut microbiota in ovarian endometriosis\u003c/h2\u003e \u003cp\u003eEndometriosis has been associated with several factors, including unopposed estrogen signaling, resistance to progesterone, altered immune function and epigenetic modifications [\u003cspan citationid=\"CR51\" class=\"CitationRef\"\u003e51\u003c/span\u003e]. Because the gut microbiota can affect estrogen metabolism and inflammation, a growing body of recent evidence suggests that the gut microbiota may be closely involved in the onset and progression of endometriosis. Microbially secreted β-glucuronidases are functional members of the estrobolome [\u003cspan citationid=\"CR52\" class=\"CitationRef\"\u003e52\u003c/span\u003e]. β-glucuronidases can deconjugate estrogen and enable it to bind to estrogen receptors, leading to its subsequent downstream effects [\u003cspan citationid=\"CR52\" class=\"CitationRef\"\u003e52\u003c/span\u003e]. Ata \u003cem\u003eet al.\u003c/em\u003e [\u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e] observed differences in microbiota composition at the genus level between the stage 3/4 endometriosis group and the control group. Patients with endometriosis may harbor more β-glucuronidase-producing bacteria to increase the level of deconjugate estrogen and therefore drive endometriosis [\u003cspan citationid=\"CR53\" class=\"CitationRef\"\u003e53\u003c/span\u003e]. On the other hand, Khan \u003cem\u003eet al.\u003c/em\u003e [\u003cspan citationid=\"CR54\" class=\"CitationRef\"\u003e54\u003c/span\u003e] indicated that higher levels of \u003cem\u003eEscherichia coli\u003c/em\u003e in menstrual blood may contribute to higher levels of endotoxin in the menstrual fluid and peritoneal fluid, which may promote the Toll-like receptor 4-mediated growth of endometriosis. \u003cem\u003eE. coli\u003c/em\u003e or endotoxin from the gut may translocate into the pelvis through enterocytes [\u003cspan citationid=\"CR54\" class=\"CitationRef\"\u003e54\u003c/span\u003e]. In this study, we demonstrated that \u003cem\u003eIntestinimonas\u003c/em\u003e increased the risk of ovarian endometriosis, while \u003cem\u003eRikenellaceae (RC9gut group)\u003c/em\u003e and \u003cem\u003eRuminococcaceae (UCG013)\u003c/em\u003e decreased the risk. It is unclear whether \u003cem\u003eIntestinimonas\u003c/em\u003e, \u003cem\u003eRikenellaceae (RC9gut group)\u003c/em\u003e and \u003cem\u003eRuminococcaceae (UCG013)\u003c/em\u003e are involved in estrogen metabolism and inflammation modulation and thus participate in the onset and progression of endometriosis. These findings should be validated in the future to help develop therapeutic interventions for endometriosis.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec20\" class=\"Section2\"\u003e \u003ch2\u003e4.4 The potential role of the gut microbiota in ovarian neoplasms\u003c/h2\u003e \u003cp\u003eIn recent years, microbial roles in cancer formation, diagnosis, prognosis and treatment have emerged as debated issues. The gut microbiota can accelerate cell proliferation or cellular death, disturb the immune system and alter metabolism within host cells [\u003cspan citationid=\"CR55\" class=\"CitationRef\"\u003e55\u003c/span\u003e]; however, the exact mechanism through which bacteria influence tumorigenesis has not been elucidated. The gut microbiome of patients with epithelial ovarian cancer differs from that of healthy women, and the abundance of beneficial bacteria, including \u003cem\u003eBifidobacterium\u003c/em\u003e and \u003cem\u003eRuminococcus\u003c/em\u003e, decreases. The gut microbiota can promote ovarian tumor progression through activation of Hedgehog signaling mediated by TLR4/NF-κB signaling [\u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e]. In addition, animal study have shown that intestinal dysbiosis can significantly provoke the activation of macrophages and consequently increase the production of TNF-α and IL-6, and ultimately contributes to the development of epithelial-mesenchymal transition, resulting in the development of advanced ovarian cancer [\u003cspan citationid=\"CR56\" class=\"CitationRef\"\u003e56\u003c/span\u003e]. In this study, we found that \u003cem\u003eLachnospiraceae (UCG008) and Ruminococcaceae (UCG011)\u003c/em\u003e were positively associated with the risk of malignant ovarian neoplasm, while \u003cem\u003eParaprevotella\u003c/em\u003e, \u003cem\u003eRuminococcaceae (UCG005)\u003c/em\u003e, \u003cem\u003eSenegalimassilia\u003c/em\u003e and \u003cem\u003eSlackia\u003c/em\u003e were negatively associated with the risk of malignant ovarian neoplasm. A study showed that \u003cem\u003eLachnospiraceae (UCG008)\u003c/em\u003e was positively correlated with the levels of proinflammatory cytokines, such as IL-6, high-sensitivity C-reactive protein and TNF-α [\u003cspan citationid=\"CR57\" class=\"CitationRef\"\u003e57\u003c/span\u003e], in the peripheral blood, possibly leading to tumor progression through its proinflammatory effect. On the other hand, Gebeyew \u003cem\u003eet al.\u003c/em\u003e [\u003cspan citationid=\"CR58\" class=\"CitationRef\"\u003e58\u003c/span\u003e] demonstrated that the relative abundance of \u003cem\u003eRuminococcaceae (UCG005)\u003c/em\u003e was positively associated with propionate, iso-butyrate acetate, butyrate, and valeric acid. These SCFAs exert anti-inflammatory effects by regulating cytokine production and immune cell functions and may inhibit tumor progression through their anti-inflammatory effects [\u003cspan citationid=\"CR59\" class=\"CitationRef\"\u003e59\u003c/span\u003e]. Since there is currently no research exploring the relationship between these gut microbiota and ovarian neoplasms, the exact mechanism connecting these four bacterial genera with ovarian neoplasms has been unclear until recently and warrants additional study.\u003c/p\u003e \u003cp\u003eTo conclude, we first provide evidence to support the causal relationship between specific gut microbiota taxa and ovarian diseases through MR analyses, thus providing effective preventive and predictive measures for ovarian diseases. However, further research is necessary to validate these findings and explore the underlying mechanisms in clinical trials and animal models.\u003c/p\u003e \u003c/div\u003e"},{"header":"Declarations","content":"\u003cp\u003eEthics approval and consent to participate\u003c/p\u003e\n\u003cp\u003eNot applicable. Only publicly available summary statistics were used.\u003c/p\u003e\n\u003cp\u003eConsent for publication\u003c/p\u003e\n\u003cp\u003eNot applicable.\u003c/p\u003e\n\u003cp\u003eAvailability of data and materials\u003c/p\u003e\n\u003cp\u003eData generated in the present study are provided within the main text and supplementary materials. Genetic instrumental variables and data sources are presented in the supplementary files. The exposure and outcome data can be obtained via www.mibiogen.org and https://www.r8.finngen.fi/.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eCompeting Interests\u003c/p\u003e\n\u003cp\u003eThe authors have no relevant financial or non-financial interests to disclose.\u003c/p\u003e\n\u003cp\u003eFunding\u003c/p\u003e\n\u003cp\u003eThis research was funded by National Key Research and Development Program of China (No. 2022YFC2703803, No.2022YFC2703000, No.2021YFC2700603), National Natural Science Foundation of China (No.82088102, No.82171613, No.82171688), Collaborative Innovation Program of Shanghai Municipal Health Commission (No.2020CXJQ01), Shanghai Frontiers Science Center of Reproduction and Development, CAMS Innovation Fund for Medical Sciences (No.2019-I2M-5-064), Clinical Research Plan of SHDC (No.SHDC2020CR1008A), Shanghai Clinical Research Center for Gynecological Diseases (22MC1940200), Shanghai Urogenital System Diseases Research Center (2022ZZ01012), Shanghai Frontiers Science Research Center of Reproduction and Development. Key Discipline Construction Project (2023-2025) of Three-Year Initiative Plan for Strengthening Public Health System Construction in Shanghai (GWVI-11.1-35), Zhejiang Province College Student Science and Technology Innovation Program (Xinmiao Plan) (2023R401210).\u003c/p\u003e\n\u003cp\u003eAuthors\u0026apos; contributions\u003c/p\u003e\n\u003cp\u003eH.H., J.S. and J.P. designed the study. X.L. and Z.L. conducted statistical analysis and drafted the manuscript. K.Z., R.H., Z.J., H.W., J.Y. and Q.L. assisted in statistical analysis and manuscript drafting. J.P. and H.H. revised the manuscript critically. All authors have read and agreed to the published version of the manuscript.\u003c/p\u003e\n\u003cp\u003eAcknowledgments\u003c/p\u003e\n\u003cp\u003eWe express our gratitude to the participants of the FinnGen study and the MiBioGen consortium for releasing the gut microbiota GWAS summary statistics. \u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\u003cli\u003e\u003cspan\u003eDumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev. 2015;36:487\u0026ndash;525. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1210/er.2015-1018\u003c/span\u003e\u003cspan address=\"10.1210/er.2015-1018\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGoswami D, Conway GS. Premature ovarian failure. Hum Reprod Update. 2005;11:391\u0026ndash;410. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1093/humupd/dmi012\u003c/span\u003e\u003cspan address=\"10.1093/humupd/dmi012\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eOral E, Demir B, Inceboz U. Endometriosis and ovarian reserve. Women's health (Lond). 2015;11:671\u0026ndash;5. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.2217/whe.15.53\u003c/span\u003e\u003cspan address=\"10.2217/whe.15.53\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHowell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am. 1998;27:927\u0026ndash;43. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/s0889-8529(05)70048-7\u003c/span\u003e\u003cspan address=\"10.1016/s0889-8529(05)70048-7\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eAdak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci. 2019;76:473\u0026ndash;93. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1007/s00018-018-2943-4\u003c/span\u003e\u003cspan address=\"10.1007/s00018-018-2943-4\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eQi X, Yun C, Pang Y, Qiao J. The impact of the gut microbiota on the reproductive and metabolic endocrine system. Gut Microbes. 2021;13:1\u0026ndash;21. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1080/19490976.2021.1894070\u003c/span\u003e\u003cspan address=\"10.1080/19490976.2021.1894070\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eZhou L, Ni Z, Cheng W, Yu J, Sun S, Zhai D, et al. Characteristic gut microbiota and predicted metabolic functions in women with PCOS. Endocr Connect. 2020;9:63\u0026ndash;73. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1530/EC-19-0522\u003c/span\u003e\u003cspan address=\"10.1530/EC-19-0522\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLindheim L, Bashir M, M\u0026uuml;nzker J, Trummer C, Zachhuber V, Leber B, et al. Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study. PLoS ONE. 2017;12:e0168390. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1371/journal.pone.0168390\u003c/span\u003e\u003cspan address=\"10.1371/journal.pone.0168390\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLiu R, Zhang C, Shi Y, Zhang F, Li L, Wang X, et al. Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome. Front Microbiol. 2017;8:324. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.3389/fmicb.2017.00324\u003c/span\u003e\u003cspan address=\"10.3389/fmicb.2017.00324\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBurgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG. Using published data in Mendelian randomization a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015;30:543\u0026ndash;52. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1007/s10654-015-0011-z\u003c/span\u003e\u003cspan address=\"10.1007/s10654-015-0011-z\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eAta B, Yildiz S, Turkgeldi E, Brocal VP, Dinleyici EC, Moya A, et al. The Endobiota Study Comparison of Vaginal, Cervical and Gut Microbiota Between Women with Stage 3/4 Endometriosis and Healthy Controls. Sci Rep. 2019;9:2204. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1038/s41598-019-39700-6\u003c/span\u003e\u003cspan address=\"10.1038/s41598-019-39700-6\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eShan J, Ni Z, Cheng W, Zhou L, Zhai D, Sun S, et al. Gut microbiota imbalance and its correlations with hormone and inflammatory factors in patients with stage 3/4 endometriosis. Arch Gynecol Obstet. 2021;304:1363\u0026ndash;73. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1007/s00404-021-06057-z\u003c/span\u003e\u003cspan address=\"10.1007/s00404-021-06057-z\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWu J, Zhuo Y, Liu Y, Chen Y, Ning Y, Yao J. Association between premature ovarian insufficiency and gut microbiota. BMC Pregnancy Childbirth. 2021;21:418. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1186/s12884-021-03855-w\u003c/span\u003e\u003cspan address=\"10.1186/s12884-021-03855-w\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHu X, Xu X, Zeng X, Jin R, Wang S, Jiang H, et al. Gut microbiota dysbiosis promotes the development of epithelial ovarian cancer via regulating Hedgehog signaling pathway. Gut Microbes. 2023;15:2221093. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1080/19490976.2023.2221093\u003c/span\u003e\u003cspan address=\"10.1080/19490976.2023.2221093\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLynch SV, Pedersen O. The Human Intestinal Microbiome in Health and Disease. NEJM. 2016;375:2369\u0026ndash;79. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1056/NEJMra1600266\u003c/span\u003e\u003cspan address=\"10.1056/NEJMra1600266\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eEvans DM, Davey Smith G. Mendelian Randomization New Applications in the Coming Age of Hypothesis-Free Causality. Annu Rev Genomics Hum Genet. 2015;16:327\u0026ndash;50. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1146/annurev-genom-090314-050016\u003c/span\u003e\u003cspan address=\"10.1146/annurev-genom-090314-050016\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey Smith G. Mendelian randomization using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27:1133\u0026ndash;63. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1002/sim.3034\u003c/span\u003e\u003cspan address=\"10.1002/sim.3034\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKurilshikov A, Medina-Gomez C, Bacigalupe R, Radjabzadeh D, Wang J, Demirkan A, et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet. 2021;53:156\u0026ndash;65. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1038/s41588-020-00763-1\u003c/span\u003e\u003cspan address=\"10.1038/s41588-020-00763-1\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eSekula P, Del Greco MF, Pattaro C, K\u0026ouml;ttgen A. Mendelian Randomization as an Approach to Assess Causality Using Observational Data. J Am Soc Nephrol. 2016;27:3253\u0026ndash;65. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1681/ASN.2016010098\u003c/span\u003e\u003cspan address=\"10.1681/ASN.2016010098\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBowden J, Davey Smith G, Haycock PC, Burgess S. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016;40:304\u0026ndash;14. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1002/gepi.21965\u003c/span\u003e\u003cspan address=\"10.1002/gepi.21965\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512\u0026ndash;25. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1093/ije/dyv080\u003c/span\u003e\u003cspan address=\"10.1093/ije/dyv080\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eVerbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693\u0026ndash;8. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1038/s41588-018-0099-7\u003c/span\u003e\u003cspan address=\"10.1038/s41588-018-0099-7\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGreco MFD, Minelli C, Sheehan NA, Thompson JR. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat Med. 2015;34:2926\u0026ndash;40. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1002/sim.6522\u003c/span\u003e\u003cspan address=\"10.1002/sim.6522\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBurgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32:377\u0026ndash;89. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1007/s10654-017-0255-x\u003c/span\u003e\u003cspan address=\"10.1007/s10654-017-0255-x\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eDavies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies a guide, glossary, and checklist for clinicians. BMJ. 2018;12:362. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1136/bmj.k601\u003c/span\u003e\u003cspan address=\"10.1136/bmj.k601\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eQi X, Yun C, Sun L, Xia J, Wu Q, Wang Y, et al. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome. Nat Med. 2019;25:1225\u0026ndash;33. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1038/s41591-019-0509-0\u003c/span\u003e\u003cspan address=\"10.1038/s41591-019-0509-0\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eYang Y-Y, Pereyra LP, Young RB, Reardon KF, Borch T. Testosterone-mineralizing culture enriched from swine manure characterization of degradation pathways and microbial community composition. Environ Sci Technol. 2011;45:6879\u0026ndash;86. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1021/es2013648\u003c/span\u003e\u003cspan address=\"10.1021/es2013648\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eInsenser M, Murri M, Del Campo R, Mart\u0026iacute;nez-Garc\u0026iacute;a M\u0026Aacute;, Fern\u0026aacute;ndez-Dur\u0026aacute;n E, Escobar-Morreale HF. Gut Microbiota and the Polycystic Ovary Syndrome Influence of Sex, Sex Hormones, and Obesity. J Clin Endocrinol Metab. 2018;103:2552\u0026ndash;62. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1210/jc.2017-02799\u003c/span\u003e\u003cspan address=\"10.1210/jc.2017-02799\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BAH, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016;535:376\u0026ndash;81. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1038/nature18646\u003c/span\u003e\u003cspan address=\"10.1038/nature18646\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMu H-N, Zhou Q, Yang R-Y, Tang W-Q, Li H-X, Wang S-M, et al. Caffeic acid prevents non-alcoholic fatty liver disease induced by a high-fat diet through gut microbiota modulation in mice. Food Res Int. 2021;143:110240. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.foodres.2021.110240\u003c/span\u003e\u003cspan address=\"10.1016/j.foodres.2021.110240\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMiller TL, Wolin MJ. Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora. Appl Environ Microbiol. 1996;62:1589\u0026ndash;92. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1128/aem.62.5.1589-1592.1996\u003c/span\u003e\u003cspan address=\"10.1128/aem.62.5.1589-1592.1996\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMorrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7:189\u0026ndash;200. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1128/aem.62.5.1589-1592.1996\u003c/span\u003e\u003cspan address=\"10.1128/aem.62.5.1589-1592.1996\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHern\u0026aacute;ndez MAG, Canfora EE, Jocken JWE, Blaak EE. The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity. Nutrients. 2019;11:1943. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.3390/nu11081943\u003c/span\u003e\u003cspan address=\"10.3390/nu11081943\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ede Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell. 2014;156:84\u0026ndash;96. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.cell.2013.12.016\u003c/span\u003e\u003cspan address=\"10.1016/j.cell.2013.12.016\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBarrett HL, Gomez-Arango LF, Wilkinson SA, McIntyre HD, Callaway LK, Morrison M, et al. A Vegetarian Diet Is a Major Determinant of Gut Microbiota Composition in Early Pregnancy. Nutrients. 2018;10:890. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.3390/nu10070890\u003c/span\u003e\u003cspan address=\"10.3390/nu10070890\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGomez-Arango LF, Barrett HL, Wilkinson SA, Callaway LK, McIntyre HD, Morrison M, et al. Low dietary fiber intake increases Collinsella abundance in the gut microbiota of overweight and obese pregnant women. Gut Microbes. 2018;9:189\u0026ndash;201. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1080/19490976.2017.1406584\u003c/span\u003e\u003cspan address=\"10.1080/19490976.2017.1406584\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eCunha NBd, Ribeiro CT, Silva CM, Rosa-E-Silva ACJdS, De-Souza DA. Dietary intake, body composition and metabolic parameters in women with polycystic ovary syndrome. Clin Nutr. 2019;38:2342\u0026ndash;8. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.clnu.2018.10.012\u003c/span\u003e\u003cspan address=\"10.1016/j.clnu.2018.10.012\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eZhou J, Zuo W, Tan Y, Wang X, Zhu M, Zhang H. Effects of n-3 polyunsaturated fatty acid on metabolic status in women with polycystic ovary syndrome a meta-analysis of randomized controlled trials. J Ovarian Res. 2023;16:54. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1186/s13048-023-01130-4\u003c/span\u003e\u003cspan address=\"10.1186/s13048-023-01130-4\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKivenson V, Giovannoni SJ. An Expanded Genetic Code Enables Trimethylamine Metabolism in Human Gut Bacteria. mSystems. 2020;5:e00413\u0026ndash;20. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1128/mSystems.00413-20\u003c/span\u003e\u003cspan address=\"10.1128/mSystems.00413-20\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eElgart M, Stern S, Salton O, Gnainsky Y, Heifetz Y, Soen Y. Impact of gut microbiota on the fly's germ line. Nat Commun. 2016;7:11280. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1038/ncomms11280\u003c/span\u003e\u003cspan address=\"10.1038/ncomms11280\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMukherjee A, Lordan C, Ross RP, Cotter PD. Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health. Gut Microbes. 2020;12:1802866. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1080/19490976.2020.1802866\u003c/span\u003e\u003cspan address=\"10.1080/19490976.2020.1802866\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol. 2014;14:667\u0026ndash;85. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1038/nri3738\u003c/span\u003e\u003cspan address=\"10.1038/nri3738\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eCorr\u0026ecirc;a-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MAR. Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunol. 2016;13:461\u0026ndash;72. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1038/cti.2016.17\u003c/span\u003e\u003cspan address=\"10.1038/cti.2016.17\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePetr\u0026iacute;kov\u0026aacute; J, Laz\u0026uacute;rov\u0026aacute; I. Ovarian failure and polycystic ovary syndrome. Autoimmun Rev. 2012;11:A471\u0026ndash;8. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.autrev.2011.11.010\u003c/span\u003e\u003cspan address=\"10.1016/j.autrev.2011.11.010\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eEbrahimi M, Akbari Asbagh F. The role of autoimmunity in premature ovarian failure. Iran J Reprod Med. 2015;13:461\u0026ndash;72.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eJiao X, Zhang H, Ke H, Zhang J, Cheng L, Liu Y, et al. Premature Ovarian Insufficiency Phenotypic Characterization Within Different Etiologies. J Clin Endocrinol Metab. 2017;102:2281\u0026ndash;90. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1210/jc.2016-3960\u003c/span\u003e\u003cspan address=\"10.1210/jc.2016-3960\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLiu K, Zou J, Fan H, Hu H, You Z. Causal effects of gut microbiota on diabetic retinopathy A Mendelian randomization study. Front Immunol. 2022;13:930318. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.3389/fimmu.2022.930318\u003c/span\u003e\u003cspan address=\"10.3389/fimmu.2022.930318\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eFu Z-d, Wang Y, Yan H-L. Male infertility risk and gut microbiota a Mendelian randomization study. Front Microbiol. 2023;14:1228693. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.3389/fmicb.2023.1228693\u003c/span\u003e\u003cspan address=\"10.3389/fmicb.2023.1228693\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eYe X, Liu B, Bai Y, Cao Y, Lin S, Lyu L, et al. Genetic evidence strengthens the bidirectional connection between gut microbiota and periodontitis insights from a two-sample Mendelian randomization study. J Transl Med. 2023;21:674. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1186/s12967-023-04559-9\u003c/span\u003e\u003cspan address=\"10.1186/s12967-023-04559-9\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eChen J-H, Zeng L-Y, Zhao Y-F, Tang H-X, Lei H, Wan Y-F, et al. Causal effects of gut microbiota on sepsis a two-sample Mendelian randomization study. Front Microbiol. 2023;14:1167416. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.3389/fmicb.2023.1167416\u003c/span\u003e\u003cspan address=\"10.3389/fmicb.2023.1167416\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eZubrzycka A, Zubrzycki M, Perdas E, Zubrzycka M. Genetic, Epigenetic, and Steroidogenic Modulation Mechanisms in Endometriosis. J Clin Med. 2020;9:1309. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.3390/jcm9051309\u003c/span\u003e\u003cspan address=\"10.3390/jcm9051309\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eErvin SM, Li H, Lim L, Roberts LR, Liang X, Mani S, et al. Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens. J Biol Chem. 2019;294:18586\u0026ndash;99. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1074/jbc.RA119.010950\u003c/span\u003e\u003cspan address=\"10.1074/jbc.RA119.010950\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBaker JM, Al-Nakkash L, Herbst-Kralovetz MM. Estrogen-gut microbiome axis Physiological and clinical implications. Maturitas. 2017;103:45\u0026ndash;53. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.maturitas.2017.06.02\u003c/span\u003e\u003cspan address=\"10.1016/j.maturitas.2017.06.02\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKhan KN, Kitajima M, Hiraki K, Yamaguchi N, Katamine S, Matsuyama T, et al. Escherichia coli contamination of menstrual blood and effect of bacterial endotoxin on endometriosis. Fertil Steril. 2010;94:2860\u0026ndash;3. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.fertnstert.2010.04.053\u003c/span\u003e\u003cspan address=\"10.1016/j.fertnstert.2010.04.053\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e. .e1-3.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGiudice E, Salutari V, Ricci C, Nero C, Carbone MV, Ghizzoni V, et al. Gut microbiota and its influence on ovarian cancer carcinogenesis, anticancer therapy and surgical treatment A literature review. Crit Rev Oncol Hematol. 2021;168:103542. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.critrevonc.2021.103542\u003c/span\u003e\u003cspan address=\"10.1016/j.critrevonc.2021.103542\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eXu S, Liu Z, Lv M, Chen Y, Liu Y. Intestinal dysbiosis promotes epithelial-mesenchymal transition by activating tumor-associated macrophages in ovarian cancer. Pathog Dis. 2019;77:ftz019. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1093/femspd/ftz019\u003c/span\u003e\u003cspan address=\"10.1093/femspd/ftz019\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eZhu Y, Li Y, Liu M, Hu X, Zhu H. Guizhi Fuling Wan, Chinese Herbal Medicine, Ameliorates Insulin Sensitivity in PCOS Model Rats With Insulin Resistance via Remodeling Intestinal Homeostasis. Front Endocrinol (Lausanne). 2020;11:575. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.3389/fendo.2020.00575\u003c/span\u003e\u003cspan address=\"10.3389/fendo.2020.00575\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGebeyew K, Chen K, Wassie T, Azad MAK, He J, Jiang W, et al. Dietary Amylose/Amylopectin Ratio Modulates Cecal Microbiota and Metabolites in Weaned Goats. Front Nutr. 2021;8:774766. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.3389/fnut.2021.774766\u003c/span\u003e\u003cspan address=\"10.3389/fnut.2021.774766\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWenzel TJ, Gates EJ, Ranger AL, Klegeris A. Short-chain fatty acids (SCFAs) alone or in combination regulate select immune functions of microglia-like cells. Mol Cell Neurosci. 2020;105:103493. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.mcn.2020.103493\u003c/span\u003e\u003cspan address=\"10.1016/j.mcn.2020.103493\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"
[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"gut microbiota, polycystic ovary syndrome, premature ovarian failure, ovarian endometriosis, ovarian neoplasm, Mendelian randomization ","lastPublishedDoi":"10.21203/rs.3.rs-4188266/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-4188266/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e \u003cb\u003eBackground\u003c/b\u003e Previous studies have reported an association between gut microbial dysbiosis and ovarian diseases, however, it is not clear whether a causal association exists.\u003c/p\u003e \u003cp\u003e \u003cb\u003eMethods\u003c/b\u003e Two-sample Mendelian randomization (MR) analysis was performed to genetically predict the causal effects of the gut microbiota on polycystic ovary syndrome (PCOS), premature ovarian failure (POF), ovarian endometriosis, and malignant and benign ovarian neoplasms. The inverse variance weighted (IVW) method was used as the primary statistical method. A series of sensitivity analyses, including weighted median, MR-Egger, simple mode, weighted mode methods, MR pleiotropy residual sum and outlier (MR-PRESSO) and leave-one-out analysis, were also conducted to assess the robustness of the MR analysis results. Reverse MR analysis was implemented to explore whether ovarian diseases have any causal impact on the bacterial genera. Additionally, the Cochran\u0026rsquo;s Q test was used to evaluate heterogeneity among instrumental variables.\u003c/p\u003e \u003cp\u003e \u003cb\u003eResults\u003c/b\u003e IVW analysis revealed that several bacteria were associated with decreased risk of PCOS, POF, ovarian endometriosis, and benign and malignant ovarian neoplasm. Moreover, several bacteria were the causes of increased risks for POF, ovarian endometriosis, and benign and malignant ovarian neoplasm, respectively. Reverse MR analysis did not reveal a significant causal effect of these ovarian diseases on the gut microbiota. These findings were robust according to extensive sensitivity analyses.\u003c/p\u003e \u003cp\u003e \u003cb\u003eConclusion\u003c/b\u003e Our results provide genetic evidence to support the causal relationship between specific gut microbiota taxa and ovarian diseases; thus, the gut microbiota should be considered a preventative strategy for ovarian diseases.\u003c/p\u003e","manuscriptTitle":"Gut microbiota and risk of ovarian diseases: a two-sample Mendelian randomization study","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-04-03 19:31:36","doi":"10.21203/rs.3.rs-4188266/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"
[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"9b82bb33-08fd-43d4-aa53-91ae01101f5a","owner":[],"postedDate":"April 3rd, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2024-05-09T04:59:41+00:00","versionOfRecord":[],"versionCreatedAt":"2024-04-03 19:31:36","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-4188266","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-4188266","identity":"rs-4188266","version":["v1"]},"buildId":"ehx78VzkSd0WSzXnipQa-","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.